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I. INTRODUCTION 
Today, small animal pets are receiving increasingly 
better care. This leads to greater longevity. The treatment 
of geriatric problems by the small animal clinician has be-
come an important phase of practice, and this phase will con-
tinue to grow. Many of these problems are centered around 
cardiac and liver pathologies, and the means now available 
for diagnosing these abnormalities in dogs often fail to give 
unequivocal information. Therefore, treatment is often 
based on intuition and past experience with no guarantee that 
the treatment is specific for the condition presented. 
As our knowledge of diseases continues to increase, 
methods to diagnose them must improve. Some of the problems 
that faced the veterinarian in recent years have been re-
solved; however, very little progress has been made in the 
area of diagnosis of cardiac problems. The electrocardio-
graph has been used as a diagnostic aid in veterinary medicim 
yet most of the information, which can be derived from it, 
is empirical since much of the interpretation of the canine 
electrocardiogram has been based on studies from the human 
electrocardiogram. 
In the past few years great advances have been made in 
enzyme chemistry. Many serum enzymes have been investigated 
and a few of them have been shown to be of value as diagnos-
tic aids in human medicine. It appears that the 
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concentrations of some of these same enzymes in blood serum 
may be used by the veterinary profession as diagnostic aids. 
The ones which have proved to be most useful in human medi-
cine in diagnosing certain abnormalities of the myocardium 
and which have given some indication of responding in the same 
manner in dogs have been serum glutamic oxalacetic trans-
aminase (SGOT}, serum glutamic pyruvic (SGPT}, and serum 
lactic dehydrogenase (SLDH}. 
The primary objectives of this investigation were to 
1) establish a normal set of values for serum enzyme levels 
of glutamic oxalacetic transaminase, glutamic pyruvic trans-
aminase, and lactic dehydrogenase in dogs; 2) to establish the 
accuracy of a clinical assay test commonly used by research 
workers; 3} to examine the usefulness of these serum enzymes 
as diagnostic indexes of myocarc.'.ial necrosis, valvular insuf-
ficiency and epicarditis; 4} to determine what constitutes a 
normal canine electrocardiogram; and 5) to define any electro-
cardiographic changes which may be of importance in diagnosing 
these pathologic conditions and correlating them with the 
changes observed in serum enzymes levels. 
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II. REVIEW OF LITERATURE 
A. Enzymes 
In the past ten years th~re has been an explosive in-
crease in interest in the enzymes of blood and other tissues . 
Many laboratories have become concerned with this intriguing 
field with considerable volumes of data being accumulated. 
Following the demonstration of the normal range of activity 
of certain enzymes in the serum of animals and man, a sizable 
experience has accrued attesting to the experimental as well 
as the clinical implications of alterations in the serum 
activity in pathological conditions of certain tissues and 
organ systems. The major part of this work was done in human 
medicine and several reviews are available which describe the 
clinical significance of these enzymes as well as some of the 
work done experimentally with dogs (15, 46, 57, 60, 101, 143, 
161). Even though much of the early work was done with dogs, 
the emphasis was soon placed on the importance of these en-
zymes in human medicine and animal data were either forgotten 
or disregarded. Very little work has actually been done by 
the veterinarian in the study of these enzymes and their pos-
sible clinical significance in diagnosis. Early studies were 
merely pilot studies and results were used mainly for compari-
son with those found in human serum levels. The early work 
in veterinary medicine has been done largely by Cornelius 
£l al. {Jl, 32,33 ) of California. 
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Many methods have been devised for measuring these 
serum enzyme levels. The first methods were based on chroma-
tography {78, 133), later spectrophotometry and colorimetry 
(17, 22, 64, 65, 76, 77, 107, 128, 134, 149, 150, 154, 163) 
then fluorimetry {87, 88). Both macro and micro determin-
ations are possible. There are available for the clinician 
today si.mple, inexpensive, clinical methods ( 14, 34, 145}. 
Clinicians, impressed by the ease of frequent, adequate 
sampling of blood and the elegance of spectrophotometric 
enzyme assay, have done a great deal of the work on the in-
vestigation of enzyme alterations. In only a few cases, 
chiefly with cellular enzymes, have any clinical studies been 
directed toward an understanding of the mechanisms of enzyme 
alterations in disease conditions. Only in the past two or 
three years have factors such as the movement of enzymes 
across cell membranes, the origin and excretion of enzymes 
of serum, the relationship to stress, the influence of diet, 
and the characteristics of these enzymes come under investi-
gation. With such studies came progress in the study of basic 
physiologic and pathologic processes as well as in the clinical 
areas. 
Enzymes are organic catalysts produced as a result of 
cellular activity but independent of the presence of living 
cells in their operation. The name "enzyme" (from the Greek, 
"in leaven"; "in yeast") is associated with the process of 
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fermentation. Enzymes act on bio-chemically important sub-
stances. One essential difference must be stressed between 
inorganic catalysts such as platinum, which catalyzes many 
chemical reactions, and organic enzymes such as SGOT, SGPT, 
and SLDH which are extremely specific. It is well known that 
most chemical reactions do not proceed entirely in one direc-
tion. Several reactions of the substrate are possible, de-
pending upon the nature of the enzyme. Because of its spe-
cificity, the enzyme catalyzes only one of these reactions. 
A chemical reaction which is reversible will attain a 
state of equilibrium when the velocity of the forward reaction 
is equal to the velocity of the reverse reaction. The factors 
whi~h influence the equilibrium state are temperature, pres-
sure, concentration of the reacting substances and the pres-
ence of a catalyst. The catalyst speeds up both the forward 
and backward reaction and thus allows the system to attain a 
state of equilibrium in a shorter time. A catalyst will not 
make a reaction proceed unless that reaction can proceed of 
its own accord, no matter how slowly. 
The chemical properties of enzymes, as well as their 
stability and solubility characteristics, are closely related 
to those of proteins. As more and more enzymes have been 
isolated in a crystalline form and have proved to be single 
components, it has become more certain that enzymes are 
indeed proteins. Recently, it has been found that certain 
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enzymes are composed of component enzymes termed isozymes. 
So far, no enzyme has been isolated which is not a pro-
tein. It is also true, however, that in many instances for 
an enzyme to be active some co-factor of a non-protein nature 
is required. These inorganic ions may be attached to the en-
t . S h . . 1 d C ++ M ++ Mn++ Z ++ zyme pro ein. uc ions inc u e a , g , , or n • 
The broad category of enzymes can be broken down into a 
classification on the basis of several criteria. In this 
research interest has been placed on a particular group of 
enzymes, termed transferases, and more specifically on a group 
of enzymes designated as transaminases. 
The role of the transaminase reaction in metabolic trans-
formations is twofold (62). First, it provides a machanism 
for the interconversion of amino acids via keto acids. Thus 
one can visualize the synthesis of an important amino acid 
like glutamic acid from alpha-ketoglutaric acid, which arises 
as the result of the oxidation of carbohydrates. In this way , 
an interrelationship between glutamic acid, aspartic acid, 
alanine and the tricarboxylic acid cycle intermediates is 
established. Secondly, transamination provides a mechanism 
for the oxidation of many L-amino acids, according to the 
following reactions: 
L-Amino acid + a-ketoglutaric acid > a-keto acid 
+ L-glutamic acid 
L-Glutamic acid + 1/2 02 a-ketoglutaric acid + NH3 
7 
Glutamic acid dehydrogenase, the enzyme involved in the 
last reaction is capable of linking the metabolism of amino 
acids and carbohydrates without the need for oxidative deam-
ination, which, in the mammal, is not quantitatively important, 
and can ·be forgotten as far as this discussion is concerned 
(62}. In addition, transamination is important in the bio-
synthesis of many amino acids. 
There is evidence that separate transaminases exist for 
the separate reactions (23}. These purified enzymes are 
stimulated by the addition of pyridoxal phosphate {vitamin B6}, 
for when an animal is placed on a diet deficient in this 
vitamin, the transaminase content of tissues decreases (62). 
In addition, the amine form of vitamin B6 , pyridoxamine phos-
phate, is also a stimulant for these enzymes. This has led to 
the hypothesis that the enzyma't.ic activity involves the inter-
conversion between the two co-enzyme factors. Meister (103) 
has suggested the following formulation of the reaction: 
Pyridoximine phosphate and enzyme ~ enzyme-pyridoxamine 
phosphate 
or (pyridoxal phosphate) (enzyme-pyridoxal 
phosphate) 
Enzyme-pyridoxamine phosphate and keto acid a enzyme-pyridoxal 
phosphate and amino acid. Jenkins (74) reports that there is 
no doubt that the over-all reaction is as follows: 
Glutamate ) ( Pyridoxal Enzyme ) 
Ketoglutarate Pyridoxamine Enzyme 
( Aspartate 
Oxalacetate 
Indications for the existence of a coenzyme activator for 
the apo-transaminases were supported by the evidence from ex-
perimental studies of vitamin B6 deficiency. Deficiency of 
vitamin B6 was associated with lowered levels of transaminase 
activity, and the addition of pyridoxal phosphate to the tis-
sue or cell preparation resulted in at least partial restor-
ation of enzyme activity (S, 12, 91, 140). Recent studies 
have confirmed earlier work on the activation of transaminase 
by pryidoxal phosphate. and have shown as well that many of 
the newly discovered transaminases also require this co-
enzyme (lOJ). 
In 1955 Marsh ~ .21,. (100) reported that in both man and 
monkeys, increasing the intake of pyridoxal resulted in a 
significant increase in the blood level of the transaminase 
and of vitamin B6• Reductions in the pyridoxal intake were 
followed by a lowering of the blood concentration of both 
factors. The changes in the level of transaminase were often 
more gradual, however, than were those of vitamin B6• The time 
required to reduce the levels to a minimum after withdrawal 
of all pyridoxine or to the initial levels after the supple-
mental dosage was discontinued seemed to be dependent to some 
extent upon the duration of the period of the increased intake. -
In 1959 Jenkins and co-workers {75) showed that glutamie 
aspartic transaminase contains two residues of tightly bound 
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pyridoxal phosphate per molecule. Their data support the 
theory that the "pyridoxal" form is more stable than the 
"pyridoxamine" form of this enzyme. 
Ranke ~ al. (126) reported on the relationship of 
vitamin B6 and transaminases in 1960. They found that there 
is a mild state of vitamin B6 deficiency among healthy, old 
adults. It was also found that these older individuals had 
a lower SQOT than young individuals, regardless of which groups 
of old and young subjects were compared. Daily oral adminis-
tration of 15 mg. of vitamin B6 to the elderly individuals 
elevated the SGOT content. The addition of pyridoxal phos-
phate to the sera in. vitro elevated the SGOT cont ent of the 
sera of old individuals. 
It is unlikely that the observed differences in SGOT can 
be explained solely by differences in dietary vitamin B0 in-
take, since this study was done on three groups of young sub-
jects and three groups of old subjects on a variety of diets. 
It does not seem that differ ences in the SGOT content with age 
are primarily due to a progressive decrease of dietary content 
of vitamin B6. On the other hand, the SGOT levels can be 
r a ised i f the intake is sufficiently large. The .!!! vit ro ex-
periment showed that the decrea se in SGOT activity in the aged 
is due primarily to the decrease in the coenzyme, pyridoxal 
phosphate, and not to the protein moiety or the apoenzyme of 
the SGOT molecule. The poss i bility of r egress i on of l eukocyte 
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pyridoxal phosphate content with age has been suggested by 
others and this could possibly be the factor involved. 
In 1950 Cammarata and Cohen ( 24) showed that at least 25 
amino acids participate in the transamination reaction. The 
reaction was catalyzed by aqueous extracts of pig heart, liver, 
and kidney (later many more tissues have been used). Each 
transamination reaction appeared to be due to a different 
transaminase. They found that the reaction was accelerated 
by pyridoxal phosphate and slightly inhibited by ammonia. 
The variety of amino and keto acids capable of partici-
pating in transamination makes it necessary to distinguish the 
different effects. Accordingly, it has become customary to 
distinguish the enzymes res~onsible for transamination reac-
tions in one of several ways. The en~ymes which catalyze 
reversible transamination reactio1.s are designated by a term 
referring to both amino acids concerned, e.g., glutamate-
aspartate transaminase. Another method of designating the 
enzymes is to name them by a term describing the favored pro-
ducts of the equilibrium reaction, e.g., glutamic oxalacetic 
transaminase {GOT) and glutamic pyruvic transaminase {GPT). 
The latter method of designation has been used in the clinical 
literature. 
Although it now appears that at least several distinct 
transaminases exist in each of the tissues that have thus far 
been studied, final characterization of the individual cataly-
tic systems is yet to be achieved. However, the chemical 
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separation and purification of the GPT and GOT of heart 
muscle have been reported by several groups (23, 55, 75). 
Both of these enzymes have also been separated from each other 
electrophoretically, using as an enzyme source, serum obtained 
from patients with hepatitis {161). It would thus appear that 
at least GPT and GOT are separable, distinct, and individual 
catalytic systems. 
Transamination was first suggested as a possibility by 
Nadham in 1927 and later demonstrated in pigeon breast muscle 
in 1937 by Braunstein and Kritzmann (19). They found that 
when L-glutamic acid and pyruvic acid were incubated with 
chopped liver or muscle a-ketoglutaric acid and alanine were 
produced, the amino group of the glutamic acid being trans-
ferred to pyruvic acid. Transamination, thus, involves the 
transferral of an amino group (NH2 ). As was mentioned earlier 
many amino acids can take part in this reaction, glutamic 
acid is especially active in this respect, and it is with 
this amino acid that this review is especially concerned. Tre 
two transaminases which have been found to have clinical use-
fulness are GOT and GPT, both of which have glutamic acid as 
part of the substrate upon which they exert their action. L-
aspartic acid may replace glutamic acid, but the reaction is 
much slower. 
The actual reactions are as follows: 
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1. L-Glutamic acid + oxalacetic acid 
! i 
a ketoglutamic acid + L-aspartic acid 
2. L-Glutamic acid + pyruvic acid 
l i 
a ketoglutamic acid + L-alanine 
According to Cohen and co-workers (30), reaction 1 pro-
ceeds to the right at the fastest rate in all tissues studi ed. 
The reaction to the left proceeds only 1/2 to 1/3 as rapidl y. 
Reaction 2 is very slow when compared with reaction 1. 
These two systems are widespread in higher plants, many 
microorganisms, and in the blood and tissues of animals and 
appear to be a function of tissues in general; the following 
descending order of concentration has been reported in man : 
heart muscle, skeletal muscle, brain, liver, kidney, testes, 
lung, and spleen (60). 
Table 1. 
Heart 
Liver 
Average distribution of enzymes in human tissues 
(µnits/gm. wet tis sue) 
GOT GPT LOH 
155,000 7,130 240,000 
43,soo 390,000 
Skeletal Muscle 
142,400 
99,300 4,750 600,000 
Kidney 90,900 19 ,300 640,000 
Pancreas 28 ,300 1,950 150,000 
Spleen 13,600 1,210 140,000 
Lung 10,000 668 25,000 
Serum 20 15 400 
(141) (141) (162) 
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In 1959 Cornelius ~ al. (3 2 ) r eported on various tissue 
activities of GOT and GPT in normal horses , cattle, ca l ves, 
pigs , dogs , and fowls. They found considerable GOT activity 
in almost all tissue analyzed in each species, but high GPT 
activity was found only in the canine liver. After t he ad-
ministration of carbon tetrachloride and during subsequent 
hepatic necrosis, significant elevations in serum GOT activity 
were found in the horse, cow, pig and dog , but marked el e -
- vations of serum GPT activity were confined t o the dog . 
Normal r anges of SGOT activity have been reported as 5 to 40 
units, of SGPT as 5 to 40 units, and of SLDH as 100 to 600 
units ( 132). 
In the r eaction shown above , pyruvic acid and oxalacetic 
acids , products of carbohydrate metabolism , are transferred 
into amino acids, thus suowing how the body is able to syn-
thesize some of its amino acids. The reverse reaction indi -
cates how the more complex gl utamic acid might be produced 
from alanine or aspartic acid and another intermediate i n 
carbohydrate metabolism , alpha-ketoglutaric acid. 
Since transamination is a rapid process and concerned 
chiefly with those compounds which play key roles in inter-
mediary metabolism, Cohen (29 ) suggests that it represents a 
"shuttle". mechanism in tissue respiration "Whereby certain key 
protein and carbohydrate intermediates are rapidly intercon -
verted" . The demonstration of transamination a f fords further 
evidence for the highly dynamic character of protein-
metabolism. Amino groups are being continually exchanged 
between nitrogenous and non-nitrogenous compounds, and amino 
acids thereby synthesized. Transamination may be important 
from another standpoint. The non-nitrogenous compounds formed 
in these two-way reactions - pyruvic acid, alpha-ketoglutaric 
acid and oxalacetic acid - are concerned in oxidation-
reduction systems. 
Under normal conditions the abundant transaminases are 
confined, almost exclusively, within tissue cells and only 
very small amounts are found in the circulation. It is this 
relatively small "baseline" serum level which first suggested 
and has permitted ready detection of increased serum values 
resulting from the destruction of tissue and the assumed re-
lease of enzyme from the large tissue stores. However, whether 
or not all the serum increase comes from the particular tissue 
involved or if some other mechanism is involved is not known. 
It is relatively certain that most of it comes from the 
damaged tissue as much work has been done showing the great 
decrease of enzyme content in the pathologic tissue compared 
with the normal (4, 82, 89, 104, 116, 131, 132). Hamolsky 
and Kaplan (60) reported that the clinical findings of LaDue, 
Wroblewski and Karmen (85) have been strongly supported by 
experimental studies of myocardial damage by several workers 
using various techniques, revealing excellent correlations of 
I 
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increased serum levels of enzyme activity with tissue damage. 
Significant elevations of SGOT, although short-lived, have 
been found with experimentally induced infarcts of less than 
1 gm. of myocardium. There was a suggestive correlation be-
tween the size of the infarct and the height and duration of 
increased serum enzyme activity. Enzyme levels decrease 
rapidly in infarcted muscle as compared with normal muscle. 
In almost every instance, serum enzyme levels were not in-
creased in the presence of significant ~yocardial ischemia 
without histologic necrosis. They further r eport that SGPT 
is frequently normal in the face of elevated SGOT in the less 
extensive infarctions, but may rise in the presence of large 
infarcts. Although it has been stated a11d generally believed 
that SGPT is not elevated until SGOT values of 150··200 units 
are reached, Rowell and Smith (130) found 14 ei.-tsodes of ele-
vation in human subjects of SGPT with SGOT values below 150 
units. 
There appears to be a highly effective mechanism for the 
rapid elimination or degradation of the enzyme from the 
serum. Dunn (40} reported on this in 195S. He found that 
following intravenous injection three-fourths of the injected 
enzyme disappeared from the blood within six hours. The re-
maining portion was cleared within 20 to 72 hours depending 
upon the amount injected. The rapid disappearance phase was 
due to a diffusion of the enzyme into the interstitial fluid. 
Equilibrium of serum and lymph GOT was reached within six to 
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eight hours and marked the end of the rapid disappearance 
phase. A diffusion of GOT from blood to interstitial fluid 
was also found following myocardial infarction and hepato-
cellular necrosis. In no case was any GOT found in the 
spinal-fluid or urine. He felt that no inactivation occurred 
in the kidney. The exact mechanism of destruction and elimi-
nation still remains obscure. 
Recently it has been suggested by Van Rymenant and co-
workers (155) that there is evidence that the elevated 
transaminase levels, found in patients with cancer, may de-
crease to normal following the administration of large 
quantities of protein. This opens the door for a vast amount 
of research upon prvtein levels and qualities and their effect 
upon serum transaminases. 
Recently, a study wa,; made of the effect of physical 
exercise on the serum GOT and GPT in humans (139). It was 
demonstrated that physical exercise of a moderately stren-
uous nature (running slowly, chin ups, swimming, and rowing) 
regularly raises the level of SGOT (in most instances to 
levels above the upper limit of normal). The SGPT, although 
showing a slight rise, tended to remain within normal limits. 
In other work involving rats, it was reported that there was 
a 2- to 6-fold increase in the serum GOT, GPT and LDH levels 
after exercise (7). This was much greater than that reported 
in man, but may be due to the longer period of exercise. 
this study in rats, pathologic studies revealed transient 
In 
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fatty changes in skeletal muscle fibers, heart, liver, kidney, 
and adrenal cortex; some rats also showed a few foci of in-
flammation and necrosis in the muscles. Highman and assoc-
iates have published several papers relating to the stress of 
hypoxia and the effect of autonomic drugs upon serum enzyme 
activities (67, 68, 69). Gollnick and Hearn (54) reported that 
LDH activity was increased in the heart ventriclar muscle but 
remained unchanged in skeletal muscle following excercise in 
rats. 
LDH refers to a group of enzymes which catalyze the re-
versible oxidation-reduction reaction between lactate and 
pyruvate, involving the conversion of the reduced and oxidized 
forms of the pyridine nucleotide (DPNH and DPN). 
+ 
Lactate + DPN 
LDH + Pyruvate + DPNH + H 
This reaction is a critically important step in the carbohy-
drate metabolic cycle and accordingly, the enzyme, a zinc-
containing compound, is widespread, having been found in 
virtually every vertebrate and invertebrate species tested, in 
almost every mammalian tissue studied, and in many micro-
organisms (60). It is also present in body fluids such as 
urine, serum, serous effusion, and cerebrospinal-fluid (162)~ 
In the presence of the enzyme, lactate is oxidized to 
pyruvate while DPN is reduced to DPNH; conversely, the enzyme 
will also catalyze the reverse reaction in which pyruvate is 
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reduced to lactate while the reduced DPNH is oxidized to DPN. 
Thus, measurement of enzyme activity can be carried out in 
either direction depending on the initial substrates employed 
and other factors, and different clinics have adopted one or 
the other method. 
Meister (102) emphasizes the fact that LDH catalyzes the 
reduction of several different alpha-keto and alpha-gamma-
diketo acids. The kinetics of LOH-catalyzed reactions have 
been explored in several reports (58, 113, l.42, 151, 159). 
Under normal conditions these enzymes are confined a l -
most entirely within the tissue cells although a small amount 
is normally found in the blood and an even smaller amount in 
the cerebrospi nal-fluid. Wroblewski (162) reported or, the 
activity of human tissues in the following order fl'Qm most to 
least: kidney, skeletal muscle, liver, heart, pancreas, 
spleen, brain, and lung (see Table 1). Unfortunately no cor-
responding figures are available for the various species of 
domestic animals. 
LDH activity varies in body fluids in response to path-
ological processes in tissues bathed by these fluids.(162). 
Necrosis of tissue results in the release of intracellular 
LDH, which finds access into the extracellular fluid compart-
ment, resulting in an increase in SLDH. In experimentally 
produced myocardia l infarction in dogs, Wroblewski (162 ) r e-
ports that SLDH increases in proportion to the amount of 
necrotic myocardial tissue. 
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The determination of SLDH requires certain precautions 
in the handling of blood specimens. Erythrocytes are rich 
in LDH, and the slightest hemolysis can significantly ele-
vate serum levels in a specimen. The erythrocytes also con-
tain transaminases, but in lesser amounts, however, hemolysis 
is to be avoided (46). Hsieh and Blumenthol (72) reported 
that serum taken from clotted blood after one hour at room 
temperature showed a 25 percent increase in LDH as a result 
of leakage from the erythrocytes. They state that it is 
i mperative to separate serum within thirty minutes after 
blood is drawn, unless refrigerated promptly. Blood can be 
stored for 24 hours with no increase in SLDH if kept at 
4°c. Plasma rrom oxalated or citrated blood should not be 
used for serum enzyme determinations.(81, 114). 
LDH is a relatively stable enzyme. Erickson and 
Morales (46) found that serum could be stored for at least 
a week at 4°c. and could be frozen for periods up to a month 
with negligible loss of LDH. King 181) found no change in 
serums stored for three weeks at 0 to ~0c., and Wroblewski 
and LaDue (167) reported no loss of activity in serum stored 
at room temperature for 96 hours. Sigma Chemical Company 
(l.45) recommends that undiluted serum be used within three 
days when stored at 4°c. or within 10 days when frozen when 
using their clinical reagents. 
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The transaminases are probably more stable than SLDH. 
Wroblewski (161) reports that storing serum at room tempera-
ture for 24 hours or at 4°c. for five days does not signifi-
cantly alter transaminase activity. It bas been reported that 
frozen samples remain stable for long periods of up to at 
least four months. 1 
Hess (66) discussed some of the possible mechanisms in• 
volved in maintenance of normal serum levels as well as the 
pathological serum levels of "DPN-dependent" enzymes. He 
states that the physiological disintegration of erythrocytes 
and other blood cells that lead to their normal end state 
might play a role in the maintenance of normal enzyme con-
centration, as may also that ef the intestinal mucosa, whose 
high cellular turnover is indicated by its high mitotic rate. 
He ~hinks that there is insufficient evidence to support 
either of these possibilities; however, the former seems more 
likely. The cellular turnover rate of muscle and nervous 
tissue is minimal and may be neglected; in addition he has as 
yet been unable to determine any arteriovenous differences in 
enzyme activity either in normal persons or in tumor patients, 
which indicates the participation of either of these tissues, 
the possible physiological internal secretion of enzymes is a 
lBuck, W. Animal Disease Eradication Division, Nationa l 
Animal Disease Laboritories, runes, Iowa. Serum enzyme 
stability. Personal Communication. 1960. 
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highly interesting aspect of the matter, but evidence for 
this is lacking at present. 
Since these enzymes are also found in the cerebrospinal-
fluid and since there have been several reports on the pos-
sible diagnostic significance of these enzymes in pathological 
conditions of the central nervous system it is of interest 
to discuss briefly the controversy over the existence of a 
"blood-brain" barrier. Its presence with respect to GOT and 
LDH has been mentioned in a few reports, usually when an ele-
vation of the enzymes in the serum was not reflected in the 
spinal fluid~ Wroblewski et 2.1. (164) reported that with LDH 
there was no relationship between serum and spinal-fluid 
activity and that each varied independently of the other, 
presumably because of a blood-brain barrier. Wakim and 
Fleisher (156) gave more definite evidence of a barrter in 
dogs with experimental cerebral infarction, in which marked 
elevations of spinal-fluid transaminase was associated with 
only minimal change of serum levels. Conversely, high serum 
levels resulting from acute hepatic necrosis were not reflect-
ed in spinal-fluid. In 1957 Lieberman and co-workers (93) 
however, reported serum transaminase elevations in 43 percent 
of patients who had suffered recent cerebrovascular accidents, 
and in whom myocardial infarction was ruled out by serial 
ECG's and absence of other clinical signs. Shortly there-
after, Fleisher, Wakim and Goldstein (50) reported moderate 
elevations of transaminase activity in both serum and spinal-
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fluid in a study of cerebrovascular disease in human beings. 
This differed from the results of their previous work with 
dogs. Green~ al. (55), on the other hand, observed no 
elevations of transaminase in the serum after cerebral in· 
farction, but did find moderate increased activity in the 
spinal-fluid in 7 of 11 patients. Later in 1957 Lieberman 
and his group did more work on this problem (92). They re-
ported cases of striking dissociation between levels of en-
zyme activity in simultaneously drawn specimens of blood and 
spinal-fluid which lend support to the hypothesis that a 
"blood-cerebrospinal·fluid barrier" is operative so far as 
GOT is concerned. In the cases in which elevation occured in 
both serum and spinal-fluid, the serum level was always 
greater than that of the spinal-fluid. There may be species 
differences which are yet to be d::i.scovered, but it is probably 
safe to assume that there is a blood-brain barrier in all 
animals for these three enzymes. However, work to support 
this hypothesis is in order. 
Recently, it has been found that certain enzymes are 
composed of component enzymes termed isozymes. In 1959 
Markert and Moller (97) proposed the term isozymes for the 
different molecular fonns in which protein can exist with the 
same enzymatic behavior. Beef heart LDH was first separated 
into two such isozymes or catalytic active components by 
electrophoresis (112). Since that time five LDH isozymes have 
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been identified in rabbit and human tissues; typical patterns 
were observed for each tissue (165). Markert and Moller (97) 
also found characteristic isozyme patterns for each tissue 
and species, and observed that the pattern for a single tis-
sue changed during embryological differentiation. Other prop-
erties of these LDH isozymes have been studied by various 
workers. 
Fleisher ~ al. (48) reported the separation of GOT from 
crude extracts of heart and liver into two fractions by elec· 
trophoresis. They could not show the presence of more than 
one component with GPT. In 1961, Augustinsson and Erne (ll) 
reported the existence of isozymes in serum GOT and GPT from 
man, cows, horses, and pigs. For all species of animals 
studied, both GPT and GOT activities were found in the alpha 
and beta globulin fractions of the serum. 
The existence of these fractions of enzyme activity in 
mammalian sera may be of importance in clinical studies. If 
the heterogenity of these enzymes is actually due to dif-
ferent molecular forms, these may differ in relative concen-
tration from one disease to another; ~.g., in myocardial dis-
ease and hepatic disorders. In addition, it may well be that 
the various fonns have different cellular origins. It follow:; 
then that such isozyme determinations would be much more 
specific as to the tissue and organ involved. 
The three enzymes are expressed as units per ml. of 
serum per minute. Karmen (77) defined SGOT activity as: 1 
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unit equals a decrease in optical density (O. D.} of 0.001 
under standardized conditions. The SGPT has been defined 
similarly. There has been more controversy regarding SLDH; 
however, enzyme activity is usually expressed in terms of 
units. A unit of LDH is defined as an increase in o. D. of 
0.001 per minute per ml. of serum (60). 
The spectrophotometric method of measuring SGOT was 
devised in which the GOT reaction is coupled to the oxidation 
of reduced diphosphopyridine nucleotide (DPNH} by oxaloacetate 
in the presence of an excess of purified water dehydrogenase. 
The oxidation of DPNH, and thereby the transamination re-
action, is followed by measuring the decrease in light ab-
sorption at 340 mµ. at which wavelength the reduced pyriaine 
nucleotides have an absorption peak. The spectrophotometric 
measurement of SGPT is accomplished by utilizing a technique 
analogous to that described for SGOT. The GPT reaction is 
coupled to the reduction of pyruvate to lactate by DPNH in 
the presence of an added excess of purified LDH. The colori-
metric methods are generally based upon measuring the amount 
of hydrazone present, which is highly colored. 
The determination of LDH is facilitated by the spectral 
properties of the coenzyme as discussed by Erickson and 
Morales (46). DPNH has a maximum light absorption at a wave 
length of 340 mµ. , whereas DPN absorption at this wave 
length is negligible. LDH can be determined spectrophoto-
metrically by measurement of the rate at which DPNH is 
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oxidized or reduced, depending on whether the reaction is 
studied from the pyruvate or the lactate side. With the 
reagents, pyruvate and DPNH or lactate and DPN, in excess, 
the measured rate of reaction is proportional to the concen-
tration of LDH in the sample assayed. In the colorimetric 
method of Sigma (145) pyruvic acid reacts with 2,4-
dinitrophenylhydrazine to form an intensely colored hydrazone 
which has a high O. D. over the broad wavelength range of 400 
to 500 mµ. Lactic acid, beta-DPN and beta-DPNH do not con-
tribute a significant O. D. at this wavelength. Therefore, 
by formation of the same hydrazone O. D., one can measure the 
varying o. D.'s resulting from the conversion of part of the 
pyruvic acid to lactic acid due to LDH activity. 
Determination of SGOT, SGPT, and SLDH activities have 
been used extensively in hllil1an medicine to aid in the diag -
nosis of myocardial infarctions and hepatic disease (9, 26, 
55, 63, 79, S2, SJ, $5, 105, 10$, 109, 124, 155, 166, 16$). 
Although SGOT and SGPT activities are elevated in both of 
these conditions, SGOT elevations more sensitively reflect 
myocardial infarctions and chronic liver disease, whereas 
elevations in SGPT activity are more constant in acute liver 
disease (20, 26, 63, 161, 167). This is also apparently 
true in laboratory animals and dogs (20, 31, 35, 49, 60, 101, 
161). There is very little infonnation relating SLDH changes 
to pathology in dogs, however, there are a few reports 
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relating to laboratory animals (16, 51, 70, 73, 96). It is 
reported that SLDH is a highly valuable indicator of myo-
cardial necrosis in humans, failure to observe elevations on 
serial testing is an important negative finding, and it af-
fords the added advantage over SGOT of a more persistent 
abnormality (up to 10 to 14 days after infarction)(60). The 
results on dogs from the small amount of work done indicates 
that SLDH is increased following myocardial infarction but 
not to as relatively as high level as SGOT (116, 127, 132). 
Several groups of workers produced vario us types of 
cardiac, liver and pulmonary pathology experimentally in 
dogs (2, 3, 4, 18, 62, 53, 83, 84, 89, 116, 127, 131, 132, 
144, 150). Their work indicated that myocardial infarction 
and liver necrosis resulted in elevation of all three enzymes. 
However, serum levels remained near normal in pericarditis, 
myocardial ischemia, valvular insufficiency and pulmonary 
infarction. One clinical report from California indicates 
that serum transaminase determinations can be of considerable 
aid in diagnosing liver pathology (170 ). Cornelius reports 
(31) that SGPT levels are used as the test of cho i ce in liver 
function in hepatocellular necros is in the dog and cat. 
Detweiler in his early w:>rk on canine cardiology re-
ported that t he incidence of car di ovascula r disease among 
dogs is considerably higher t han is generally r ealized (37 ). 
J 
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He further states that there is little understanding of the 
degree and character of cardiovascular involvement and that 
myocarditis and myocardial degeneration generally go unrecog-
nized, except at necropsey. 
Since then it has been reported by workers at Pennsylvania 
(3$, 39) that the incidence of heart disease in dogs of all 
ages selected at random is about 15 percent, it appears that 
more l't'Ork should be carried out on the value of these serum 
enzymes in the diagnosis of various pathological conditions 
occurring in this species. 
B. Electrocardiography 
Volumes of descriptive literature are available on the 
configuration, timing, and lead systems relevant to electro-
cardiograms of man and animals. Although many workers have 
made significant contributions to the study of the electro-
cardiogram, two are especially noteworthy both for the merit 
of this work and for their influence on the approach taken by 
others in this field as it relates to the human subject. As 
described by Abildskov (1), the early history of electro-
cardiography is dominated by the work of Sir Thomas Lewis. 
In a very short time, use was made of his observations to form 
an important part of the clinical evaluations of patients. 
Wilson played a similar role in the history of electrocardio-
graphy in later years (1). His contributions may be summar-
ized as the application of mathematics and basic principles 
of physics to this study, and resulted in bringing order to 
a field which would otherwise consist of a bewildering col-
lection of empiric data. 
During the past few years the techniques employed in 
human clinical electrocardiography have undergone relatively 
little change , although a new type of recording, the spatial 
vectorcardiogram, has been developed recently. The 1943 
recommendations of the American Heart Association's committee 
on standardization of electrocardiographic nomenclature and 
precordial leads have been widely adopted, and both the range 
of usefulness and the limitations of the electrocardiogram as 
currently used have been well defined. The technique of 
spatial vectorcardiography is still in its infancy and new 
discoveries about it are still occurring and hence it is not 
so clearly defined. 
The boundaries and guidelines which are so well provided 
for the human electrocardiogram have not been so clearly de-
fined for the canine electrocardiogram. Although volumes of 
literature are available, on canine electrocardiography, most 
of the information is empirical with much of the nomenclature 
and guidelines being borrowed from those set down for the hunan 
electrocardiogram. Much of this literature is worthless in 
the light of newer information, especially since the major 
differences between the human and canine anatomy have been 
r ecogni zed. However, the basic electrical phenomena occurring 
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within the dog's heart and the human heart are very similar 
and this does furnish some basis for the exchange of infor-
mation between the two species physiologically speaking . 
Work cited in the following review is on dogs unless other-
wise stated. 
The structure of clinical electrocardiography has been 
built on limited knowledge of the sequence in which electrical 
events involve various portions of the heart. The general 
path of activation in the atria was relatively easily defined 
because these structures are thin and for most purposes the 
spread of electrical events through them may be considered 
as surface phenomenon (1). Ashworth and Nahum (10} describe 
an auricular electrocardiogram showing a QRS wave, an ST seg-
ment, and a T wave. It is a well kLown concept that the 
impulse starts at the S-A (sino-atrial) node located in the 
right atrium. The innervation to and of the dog 's heart was 
described and discussed by Tcheng (152). Puech ~ ~. (125 ) 
described the septal auricular activation as occurring from 
above downward, and from back forward. They reported, con-
trary to the classical concept, that the posterior-inferior 
region of the left auricle, near the entrance of the pul-
monary veins, was found to be the last zone of activation. 
They found the conduction rate of the right atrial body and its 
appendage range from 487 to 1,000 mm/sec. In reference to 
t he P wave, in most cases, sinus activity takes place from 
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.005 to . 015 seconds before inscription of the P-wave. The 
end of the right auricular activity never goes beyond the 
apex of the P-wave. The left auricular activity encompasses 
most of the ascending segment of P, to the middle or lower 
third of the descending portion of the wave. 
The impulse travels from the auricles tothe ventricles 
through the A-V node also terms the bundle of His. Alanis 
and Guillermo (6) reported on the propagation of impulses 
through this structure and the connection to the Purkinje 
cells of the ventri cles. There is much controversey about 
the sequences of electrical events within the ventricles. 
The events of activation on the surface, unlike those of the 
auricles, cannot be presumed to indicate the same as that in 
the underlying muscle, because of the thickness of the muscle 
mass and the iinding of various types of nervous tissue t here . 
The classical study by Lewis and Rothschild (90) indi-
cated that activation began high on the septal wall. Later 
Sodi-Pallares et al. (148) and Burchell and associates (21) 
found evidence indicating that the apex of the septum was 
excited before the base. Harris' (61) findings generally con-
firmed those of Lewis, whereas the re sults reported earlier 
by Nahum and co-workers (110) were similar to that of the 
groups of Sodi-Pallares and Burchell. 
More recently Scher et al. (135 , 136, 137, 138) and 
Durrer et al. (42, 43, 44, 45) have investigated t his 
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phenomenon independently using similar techniques. Both 
groups confirmed earlier studies indicating that the general 
sequence of activation of the left ventricular wall proceeds 
from apical toward basal regions. Scher's et~. studies, 
which included study of the intraventricular septum, also 
confirmed the finding that the left side of the septum was the 
earliest portion of the ventricular muscle to be activated. 
His results indicated that activation begins in the mid por-
tion of the left septal endocardium. Results of the two 
groups differed with regard to the manner of excitation in 
the subendocardial regions. Both found a very rapid acti-
vation of the endocardial surface of the ventricular wall as 
did Harris (61). Studies by Scher's group, however, indi-
cated a spread of activation through the remainder of the 
ventricular wall in an endocardial to epicardial fashion. 
Harris also reported this and that the spread through the wall 
was much slower than the activation of the entire endocardium. 
The results of the work by Durrer and associates seem to indi-
cate myocardial extensions of the Purkinje system so that 
activation in the inner layers may be progressing toward the 
endocardium as well as the epicardial surfaces. In this 
respect the findings of Durrer are similar to those of 
Prinzmetal and associates (122). 
In 1961 Durrer et al. (41) reported that the question of 
intramural extension and the degree of this extension of the 
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Purkinje network is still not solved. They have looked for 
evidence of such a network in the left ventricular wall for 
years, but never found it. Previous reports gave only in-
direct evidence for its presence. However, they did find 
such an intramural extension in goats as has been repo~ted by 
other workers (106). It again must be pointed out that there 
is danger in over extrapolation from one species to another. 
In the outer layers of the ventricular wall the exci-
tatory process progresses with nearly constant velocity, 
approximately 50 cm. per second, toward the epicardial sur-
face (41). The ventricular septum is activated from both 
sides (137). No functional boundary between the portion 
supplied by the right and left bundle can be demonstrat~d. 
(137). The basal regions of the septum are activated latest 
in the cardiac cycle; therefore, the excitation wave in the 
ventricular septum progresses in an apico-basal direction (41). 
Pruitt, Essex and Burchell (123) related the speed of 
activation to direction of the muscle fibers. They stated 
that endocardial activation is rapid, not because of the 
Purkinje fibers, but because the subendocardial bonds of the 
~yocardial muscle form a network through which excitation can 
move rapidly along the axis of the fibers. Spread across the 
septum in bundle branch block and across the free wall of the 
left ventricle in the normally activated heart is slo\~ because 
excitation is moving through fibers in which the long axis is 
perpendicular to the advancing wave of excitation. 
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Hamlin and Smith (59} have summarized the data and ex-
plained the series of events as follows: After the excita-
tory impulse traverses the atrioventricular nodal conduction 
system, it is quickly carried by the Purkinje fibers to all 
areas of the endocardium and subendocardium at a velocity of 
2.5 meters per second. The Purkinje system affords a method 
whereby almost all areas of the ventricles are stimulated and 
therefore contract simultaneously. Activity represented 
electrocardiographically occurs only when the wave of exci-
tation traverses muscle by conduction from fiber to fiber. 
The electrocardiograph is silent during the time when the 
Purltinje system alone is carrying the impulse. The first area 
activated is the interventricular septum. After this septal 
activation, the impulse spreads by fiber-to-fiber conduction 
through the ventricula.:- myocardium from subendocardial termi-
nations of the Purkinje system to the epicardial surfaces. 
This activation occurs simultaneously through both ventricles. 
However, the peripheral electrocardiogram, which represents 
the resultant of the simultaneous activities of both ventri-
cles, is recorded as if the front were moving only from the 
left ventricular endocardium to the left ventricular epi-
cardiwn because the left ventricle is 4 to 6 times as thick 
as the right. Finally, the ventricular activation process is 
terminated when the base of the heart is activated in an 
apicobasilar direction. 
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Despite the conflicts of these reports it is apparent 
that much of the electrical impulse phenomenon of the heart 
is fairly well understood and that it is from these facts that 
clinical interpretations can be made. However, it is obvious 
that when a detailed order of activation is defined, the 
electrocardiogram will give a much more realistic picture of 
the location of the lesion involved in cardiac pathology. 
The repolarization pathway has presented even more dif-
ficulties in its study. It cannot be investigated with the 
methods applied to the analysis of depolarization because 
opening the thorax changes the T wave. The literature is 
notably lacking in explanations for this phenomenon. Al-
though there are several papers in the available English 
litera·ture, only one seems worthy of mention at this time. 
Studies by Reynolds and VanderArk (129) show that in general 
the order in which local ventricular muscle units recover 
excitability is correlated with the epicardial T-waves as 
recorded in direct unipolar leads. The effective refractory 
period was determined at the surface and in the deeper layers 
of the dog heart and was correlated with the surface T-waves. 
A small delay in recovery of cardiac excitability appeared 
at the surface when T-waves were negative and in the deeper 
layers when T-waves were positive. They further showed that 
both surface and deeper layers in a limited area normally com-
plete recovery within a short space of time, thus suggesting 
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that a majority of cardiac fibers recover during the same 
period of time. Since only slight changes in the rate of 
recovery at the surface or in the deeper layers are appar-
ently necessary to alter the polarity of the T-wave, this 
partly explains the !ability of the T-wave. However, it is 
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apparent that this is not a complete explanation of the origin 
and direction of the T-wave. This phenomenon awaits further 
study and clarification. 
Abildskov (1) has gone into a brief discussion of the 
origin of bioelectric potentials. It is beyond the scope 
of this paper to delve into the vast amount of research in 
this area of biochemistry and biophysics. However, as he so 
aptly points out, considerable clinical usefulness of the 
electrocardiogram has been achieved in spite of only meager 
knowledge of the processes which give rise to the electric 
phenomenon of the heart. Hamlin and Smith (59) state that 
the heart is an electric generator within the thorax and that 
an electrocardiogram is a tracing of variations in body po-
tential which has been generated by the heart and transmitted 
through the body volume to a surface point. 
In this same paper they point out the variation in the 
anatomy of the dog and man and the danger of over-
extrapola tion from species to species. 
Eyster, Meek, and Goldberg {47) reported on the relation-
ship between the ele ctrical and mechanical events of the dog 
heart. They concluded that dif ferent local regions of the 
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dog's heart start contracting at different time instants and 
that the occurrence of mechanical activity is coincident with 
or separated by a brief interval from the occurrence of maxi-
mum flow of electric current and maximum time rate of change 
of current, resulting from a potential gradient established 
between neighboring regions in which the potential is respec-
tively above and below the potential of the resting muscle. 
At the present time the author knows of no textbook which 
is primarily concerned with canine electrocardiography. How-
ever, for a basic understanding of the principles underlying 
this science the reader is referred to texts by Wolff (160) 
and Marriott (99). 
While position during recording and methocs of place-
ment of electrodes are well established for human electro-
cardiography there is much controversy in canine electro-
cardiography. The general concensus seems to be that dogs 
should be placed in lateral recumbency on their right side 
(10, 38, $6, 94, 95, 146, 153, 157). However, there is evi-
dence that the supine position is best (71, 115, 121). In 
preliminary studies by the author, the sternal position was 
found to give good reproduceability. Wallace in his treatise 
on technique of canine electrocardiography states that having 
dogs on their right sides is the technique of choice (157). 
Katz and co-workers (80) reported on positioning in 1934, 
stating that there were variations in the electrocardiographic 
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tracings with dogs placed on their right sides, but they felt 
this was due to normal variations in the position of the 
heart. They found changes in amplitude and even direction of 
all complexes, especially the T-wave. They found these same 
changes · when animals were recorded in the normal standing 
position. Lannek in his classical work also preferred the 
right side (86). Lumbard and Witham (95) varied positions on 
50 dogs and found variations in all positions from dog to dog. 
The effect of changing of position varied in a random way. 
Peterson et ~. (121) used the supine position because of the 
variabilities previously reported from the right lateral 
position. They reported that variations were much less in 
the supine positions than those reported in the lateral posi-
tion. Horwitz, Spanier, and Wiggers (71) using the supine 
position reported ·,,hat variations on the same dog taken at 
different times were as great as among different dogs. 
Newton, Ellis, and Zaremski (115) recently described a 
technique in which they reported that virtually no contour 
changes in serial electrocardiograms occurred on anesthetized 
dogs in the supine position, and it is therefore suitable for 
chronic experiments. Because of the random changes in the 
recording Lumbard and Witham (95} stressed the fact that it 
is important to have the dog in the same position in chronic 
experiments to insure correct interpretation of serial re-
cordings. Tsagan (153) recently reported that changes in 
ECG following myocardial infarction were most marked when the 
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dog was on its right side with the right front leg forward 
and the left ba ck. He reported that the position of the front 
limbs altered the Q and T-waves, and had a considerable effect 
on the ST interval. It is therefore of importance to main-
tain the front legs in a fixed position when recording the 
electrocardiogram. 
Litvak, Siderides, and Vineberg (94) summarized ex-
treme variation of the elect rocardiogram of the dog as com-
pared with the human as bei ng due mainly to positional change. 
The heart of the dog lies more centrally in the thorax and 
assumes a more vertical position than does the human heart. 
The absence of the mediastinum as compared with the human 
being , makes the heart easily susceptible to positional 
changes. Conse quently, pneumothorax, paralys is of the dia -
phragm ) abdominal distention, and even variations in heart 
rate tend to di splace and rotate the heart producing electro-
cardiographic changes. 
The clinical approach to position seems to favor having 
dogs positioned on their right sides1 (38 , 86, 157). 
The use of needle electrodes, wires, plate electrodes, 
and clambs of var ious types has been descri bed in the liter-
ature (38 , 80, 86 , 94 , 115, 121 ). Clipping of hair or 
leaving it in place do es not effect the recording (120, 121}. 
lBaker , D. L. Professor Medicine and Surgery. Iowa 
State University, Ames, Iowa. Positioning dogs for clini cal 
ECG recordings. Private communication. 1962. 
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The use of anesthetics and tranquilizers has been described 
as having little effect upon the electrocardiogram (153, 157). 
The use of morphine is to be avoided because it increases 
vagal tone (157). Cannard et s1,. (25) discussed the electro-
cardiogram during anesthesia in the human. 
The placement of electrodes upon the animal body has 
been quite clearly defined in regard to limb leads (146, 
157). However, there is some discrepancy among various 
workers as to where precordial lead electrodes should be 
placed or even if they should be used at all (38, 86, 95, 
115 , 146' 157). 
Several papers have reported on the configuration of the 
electrocardiogram of normal dogs. The results have varied 
from one group of workers to another, partly because of dif-
ferent techniques, but probably more important because of the 
normal variation in the canine electrocardiogram. In 1949, 
Lannek (86} published a detailed statistical analysis of the 
nonnal canine electrocardiogram, together with observations 
on a series of animals showing electrocardiographic abnor.~ 
malities. This work served as a cornerstone of clinical 
canine electrocardiography in the following years. Petersen 
~ g].. (121) reported on the electrocardiographic tracings in 
nonnal beagle dogs in 1951. Following this there were papers 
by Grollman and co-workers in 1952 (56), Horwitz, Spanier and 
Wiggers in 1953 (71), Soave in 1954 (146) and Lombard and 
Witham in 1955 (95). The following tables s ummarize findings: 
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Table 2. Heart rate of normal dogs 
No. 
of Breed Position 
do s 
Range Ave. Author 
32 Beagle Supine 90-1$0 138 (121) 
50 Indeterminate Right side 62-158 100 ~95) 30 Mongrel Supine 72-162 121 71) 
50 Indeterminate Right side 80-160 (146) 
Lannek (86) reported that sex differences are not 
probable in electrocardiographic tracings. He also found that 
breed differences are improbable except for the amplitude of 
the T-wave on certain breeds (collie, dachbrache, dachshound, 
greyhound, harrier, rottweiler and setter) being greater. He 
did find significant differences in certain parts of the com-
plex based upon age difference. He also reported a signifi-
cant difference in heart rate among dogs less than six months 
and those over but no additional differences with increased 
age. 
The time duration of the various segments and the ampli-
tude of the various waves as reported by other workers are 
shown in Table 3 and 4. In preliminary investigation the 
author found considerable differences in amplitudes from day 
to day and from position to position and it is thought that 
the relative rather than the absolute amplitude is of more 
significance. Lannek states that the R amplitudes are in 
themselves of no great diagnostic value, they become 
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important on low voltage and on calculating the negative T-
wave as a percentage of the R amplitude. He also states that 
the variations in amplitudes of the tracings, measured at 
four-five hour intervals during one day are considerable. 
Table 3. Time duration (seconds) of various segments of 
ECG complex as reported by others 
p P-R QRS QT Ref. 
Average 
Range 
Average 
Range 
Average 
Range 
Average 
Range 
Range 
Range 
.07 
• 04-.12 
.06 
.02-.10 
• 04-.08 
.106 
.os-.12 
.10 
.oa-.15 
.12 
.10-.15 
.106 
.06-.17 
.08-.10 
.06-.1$ 
1046 
.04-. 06 
.05 
.04-. 06 
.06 
.04;-. 08 
.045b 
• 0)-.06 
.03-.06 
.OJ-.08 
.19 
.14-. 24 
.26 
.20-.38 
.21 
.16-.28 
.187 
.14-.25 
.16-.21 
(121) 
(95) 
(71) 
(86)a 
(146) 
(56) 
aLongest iLterval in standard leads I, II, III, and aVF. 
bMedium weight breeds. 
Lannek (86) reports the P wave is often isoelectric in 
lead I and the amplitudes are never high. In leads II and 
III, P is in nearly every case positive on inspiration but 
may become negative in lead III on expiration. A P-wave which 
remains negative throughout should be regarded as an ab-
normality in all leads with the exception of lead I. 
There has been much discussion of the presence and sig-
nificance of Q-waves in the canine electrocardiogram. So much 
Table 4. Amplitudes of the various components of the dog ECG as reported by 
others (1 cm.• 1 mv.)a 
Q R § T Ref. 
Leag I 
0 (0-.2) .35 (.15-.70) 0 (0) 0 (-.1-.1) (121! .10 ~ • oo-. 60) • 3 ( • 00-1. 00 ~ -.03 1-.30-.15) !95 .16 0-1.15) 1.05 (.20-2.22 .09 ~0-.80) .05 -.36-.63) 71 
• 03 ( o-. 6) .12 (0-.35) .01 0-.2) -.005 -.1-.7) 56 b 
.77 1.11 .45 (86~ 
.14 .7 .06 .05 (146 c 
Lead II 
(0-.20) 1.8 ~l.0-2.7) .25 (0-1.0) .3(~05-.8) (121} 0 
• 24 ( o-. 90) 1.14 .25-2.30~ .10 (0-1.50) -.07 (-.45-1.00} (95) 
.17 (0-.89) 1.77 ~-30-J.09 .09 (.0-.79) .18 (-.27-.74) (71~ 
.04 ~0-.10) 1.08 .10-2.3) .14 (0-.40) .15 (-.10-.60) (56 b 
1.02 2.52 • 55 ( 86) ~ 
. 21 1.7 .09 .J.4 (1.46)C N 
Lead III 
.1 ~-1-.2~ 1.5 ~-9-2.5} .4 (0-1.4~ .3 (.1-1.0) (121) 
.12 o-.45 .76 .05-1.35) .14 (0-2.5 -.03 (-.25-.70) (95) 
.13 (0-.44) 1.11 ( .14-2.43) .23 (0-1.48) .13 ~-.26-.81) 
mlb .02 (0-.35} .92 (.1-1.95} .16 (0-.6) .16 -1.0-.6) .62 2.09 .71 (86 
.12 1.00 .18 .15 (146 c 
Lead aVF 
0 .67 (.5-1.3) .05 (0-.25) .11 (-.1-.4) (56~ 
.17 (0-.7) 1.35 (.1-2.52) .17 (0-.67) .13 ( - • 25 - • 74) (71 
aAverage and range. 
bupper limits of normal amplitude. 
cAverage only. 
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importance has been attached to this complex presumably be-
cause of its diagnostic importance in human electrocardio-
graphy in myocardial infarction. Lombard and Witham (95) re-
ported that Q-waves appeared in all three limb leads in 60 
percent of the records, in 32 percent in leads II and III and 
in the other 8 percent they occurred in one or more leads or 
were not present at all. They found the Q/R ratios in lead I 
never exceeded 2.5:1. However, they found by changing posi-
tion of the dog from its right side to its back, belly or left 
side they could cause a reduction in size or a disappearance 
of the Q-wave. They further reported significant day-to-day 
variations in leads I and II, but not in lead III. Horwitz 
et al. (71} found a Q-wave in approximately 1/3 of their 
tracings in lead I and in 82 percent this was followed by an 
inverted T-wave. They reported that Lalick he.d found this 
occurring in 78 percent of his records. However, Lombard and 
Witham (95) couldnot confirm these results. 
Probably one of the most baffling aspects of canine 
electrocardiography is the extreme variability of the T-wave. 
This is reported and discussed in almost all the papers deal-
ing with the normal canine electrocardiogram. Without going 
into a detailed discussion it will suffice to say that this 
variability is apparently normal and until the underlying 
phenomenon which causes this particular compl ex is better 
understood this will, in all probability, stand. Horwitz 
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et al. (71) did find that in 84 percent of the cases in which 
an S-wave was recorded in lead III of l mm. or more, an upright 
T-wave followed. They reported Lalick had recorded this same 
occurrence in 75 percent of his tracings. Petersen's group 
(121) found on serial recordings that in no instance did a 
positive T-wave in leads II, III, and aVF become negative. As 
mentioned earlier Lannek (86) found a deeper negative T-wave 
in leads II and III of certain breeds. He noted that this 
might be attributed to the temperament of the breeds involved. 
Bellet, Gazes, and Steiger {13) reported typical T-wave 
patterns observed in acute infarction and in those dogs with 
small infarcts involving chiefly the endocardial portion of 
the left ventricle. ln the former, observed in transmural in-
farcts, the T-waves were characterized by inversion and an 
increase in amplitude. The 'Latter showed inversion and a 
diminuation inamplitude which remained small. It should be 
remembered that they had control electrocardiograms to compare 
with before pathology occurred. 
Another important segment deviation occurrence which has 
been studied extensively is the ST segment. This also has 
been important in human electrocardiography. In preliminary 
studies the author found it to be the most reliable of any 
change in the recording for detecting cardiac pathology. 
Petersen (121} found that there was sometimes depression or 
elevation of the ST segment up to 1 mm. in dogs in the 
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supine position, chiefly in leads II, III, and aVF. Groll-
man ~ 2].. (56) found no deviation in lead I but up to 2 mm. 
up or down in leads II, III, and aVF in 18 nonnal dogs in the 
supine position. Litvak, Siderides, and Vineberg {94) found 
only a slight ST elevation in lead I in one of 12 normal dogs. 
Lombard and Witham {95) make the comment that the merging of 
the terminal part of the QRS complex with the ST-T segment is 
so characteristic a picture of the dog electrocardiogram when 
taken under anesthesia at a paper speed of 50 mm/second that 
it must be considered normal. They found it occurring to some 
degree in all leads. They further found that in the limb 
leads, 22 percent of the records showed no S-T deviation. JO 
percent up to .09 mv. and 48 percent between .10 and .20 mv. 
Other authors reporting S-T deviations of this order of mag-
nitude have attributed the phenomenon to a variety of experi-
mental causes or as a "normal" occurrence. They .round that 
on day-to-day recordings that the shift was most noticeable 
in lead II. Nahum, Hoff, and Kisch {111) reported from their 
experimental work that elevations of the R-T in any lead 
denotes damage to the surface of the left ventricle, while 
depression of the S-T indicates damage to the right ven-
tricle, however, this appears to be an over simplification 
of the situation. Lannek (86) states that the shifting of 
the ST segment towards the negative side, is clinically, by 
far the most important factor . He states that the ST segment 
may be described as a straight line or, seen from above, a 
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concave or convex curve. The straight and the concave forms 
are the most common, whereas the convex type is seen less 
often in normal cases but is relatively common in myocardial 
lesions. He further states that most of the deviations from 
the normal picture are to be found in the ST segment and the 
T-wave, in the form of depression of the ST, decrease of the 
T amplitude and shifting of the T/R relation {negative T ex-
pressed as a percentage of the amplitude of R in the same 
complex) towards higher values. The depressions of the ST 
segment are usually small although in many instances signifi-
cant. The cause is probably currents of injury. 
Durrer ~ al. (41) found that all epicardial complexes 
show S-T elevations from an ischemic area when recording 
directly through an open thorax. Detweiler, Hubben, and 
Patterson (3$) found early myocardial degeneration and 
arterial thickenings upon necropsy of three hearts of dogs 
showing an RS-T segment deviation of .2 mv. or greater in 
several leads. Tsagan (153) describes in great detail the 
changes occurring in the ST segment following experimental 
myocardial infarction. Zao, Yen, and Herrmann (169) studied 
the effects of oxygen gradient upon the ST segment. The ECG 
revealed a positive correlation between the ST segment ele-
vation and the oxygen gradient, 1.~., the ST segment increased 
in height with an increasing oxygen gradient, and decreased in 
height with a decreasing oxygen gradient. They discus sed the 
possibilities involved. 
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The question of arrhythmias is often brought up in the 
dog. Because of the normal sinu~. arrhythmia of the dog's 
heart it is often difficult to detect the abnormal arrhy-
thmias without the use of the electrocardiograph. Almost any 
type of arrhythmia, other than the normally occurring sinus 
arrhythmia can be detected by the electrocardiograph and can 
be considered as indicating cardiac pathology (86). 
Ventricular extrasystoles (ectopic beats) are rare in 
dogs and available evidence (36, 37) indicates that myo-
cardial lesions are usually present when this arrhythmia is 
encountered under clinical conditions in dogs which have 
received no drugs or toxins known to cause ventricular pre-
mature beats. Lanaek (86) also states that ventricular 
extrasystoles and block are regarded as significantly ab-
normal features, not appearing in the normal animal. 
Patterson and co-workers (120) concur with this opinion. 
The knowledge in this basic field of electrocardio-
graphy is advancing rapidly and as more infonnation is ob-
tained the increased understanding of the physiology involved 
will aid in the clinical application of this knowledge. Thus, 
treatment will be based increasingly on facts instead of 
empiricism. 
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III. METHODS AND MATERIALS 
A. Procurement and Care of Normal Dogs 
A total of 50 normal, mongrel dogs of all ages and both 
sexes were used in this study. As dogs were obtained by the 
Department of Physiology and Pharmacology, they were given a 
complete physical examination as described by Detweiler ( 38) 
which included observation of the condition of the animal, 
palpation, and auscultation of lungs and heart. Dogs which 
appeared to have some abnormal characteristics were discarded 
at this point. Those dogs which appeared normal then had a 
complete hematological examination including hematocrit and 
hemoglobin detennination, total erythrocyte count, total 
leukocyte count , and a differential leukocyte count. Dogs 
having hematolo~;ic values within nonnal ranges were kept for 
surgery, provided the presurgical electrocardiogram appeared 
to be nonnal. Table 5 shows the results of the blood studies 
of the normal dogs. A vaccination programl over a five-week 
period prepared the animals for further experimental use. 
The animals were vaccinated with 1 cc. of an antigen2 intra-
dermally at 7-day intervals for five weeks. A serum sample 
1 Booth, R. R. 
Distemper-hepatitis 
1960. 
2virogen D-H: 
3920 E. Jackson Blvd., Elkhart 1 Indiana. Immunization. Personal Communication. 
Pitman -Moore Co., Indianapolis, Indiana. 
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was collected from all dogs at this point and again prior to 
any surgical procedure for enzyme determination (see Table 6). 
The cages in which the dogs were housed were made of 
galvanized iron. They were cleaned twice daily. Water and 
1 dry commercial dog food containing 24 percent protein and 
6 percent fat were fed ad libitum to the experimental dogs. 
Dogs were divided into three groups as to age for pre-
surgical ECG recordings. Dogs in group I were 4 to 12 months 
of age; group II, one year to five years; and group III, over 
five years. Estimation of age was based entirely upon appear-
ance and characteristics of teeth. 
B. Blood Serum Enzymes 
SGOT was measured by the method of Hergt and Langin 
(64) (eee appendix) which is a slight modification of Ka' rmen's 
original procedure (77). SGOT, SGPT, and SLDH _were measured 
by the clinical Sigma methods (14, 45). The Sigma method of 
SGOT determination was compared with the research method of 
Hergt and Langin (see Table 7). All determinations were made 
using the Beckman Model B spectrophotometer. 2 All blood 
samples collected for serum were allowed to clot, immediately 
centrifuged, the serum removed with pipettes, placed in 15 ml. 
1General Mills, Minneapolis, Minnesota. 
2Beckman Instrument Co. 1 Instruments Division, 2500 Ful-lerton Road., Fullerton, California . 
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test tubes, and sealed with waxed corks. These samples were 
frozen immediately and sixteen samples were run at a time at 
various time intervals later. In preliminary trials it was 
found that very little loss in activity from freezing occurred; 
however, it has been reported that repeated freezing and 
thawing will decrease enzyme activity. 1 SLDH samples were 
not stored in the freezer for longer than ten days. 
c. Electrocardiography 
Electrocardiograms were taken with the Sanborn Viso-
cardiette Model 51 electrocardiograph. 2 Needle electrodes 
were placed subcutaneously as the dog was placed on its ster-
num and belly, front limbs extended ~traight forward with 
head resting between them, and hind legs directed to the 
rear. The standard limb leads I, II, III were recorded plus 
augmented unipolar limb lead aVF. The needles were placed 
in a position adjacent to the lateral epicondyle of the femur 
and radius. (Shown in Figure 10, Appendix). A small area of 
hair was kept clipped at these points so as to insure placing 
the electrodes in the same position each time a recording was 
made. A recording was taken prior to surgery and if the ECG 
appeared to be normal, surgery was performed as described 
later. Several recordings were made at various intervals 
lauck, w. Animal Disease and Eradication Division, 
National Animal Disease Laboratories, Storage of Serum-
Enzymes, Personal Communications, Ames, Iowa. 1960. 
2sanborn Co., Medical Division, Waltham, Mass. 
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following surgery to monitor any changes in the electrical 
phenomenon of the heart. All recordings were made while the 
dogs were anesthetized with sodium pentobarbital (prior to 
and immediately following surgery) or while they were tran-
1 
quilized with promazine hydrochloride (later serial studies). 
Methods of measuring the electrocardiogram were quite 
similar to those used by Lannek (86). The isoelectric line 
was established as being that segment of the cycle extending 
from the end of the T-wave to beginning of the P-wave. Seg-
ments for measuring, if possible, were selected where the base 
line runs parallel to the paper and where the lower contour 
of the preceding and succeeding T-P segment and the engraved 
line have formed a straight line. 
Errors due to measuring have been minimized through 
multiple determinations. Lannek (86) found that the error of 
measuring vanes with the technical quality of the tracings. 
He found that 99.7 percent of the error of measurement for 
amplitudes may be considered to lie within the limits ~ 0.48 
mm. , and that for durations within~ 0.012 seconds. 
All amplitudes and durations were measured with dividers 
and then calculated from a known set of refer ence points . In 
those cases of an odd time interval it was rounded off to the 
1Promazine Hydrochloride - Fort Dodge Laboratories, Inc., 
Fort Dodge, Iowa . 
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nearest even interval, i.~., the duration has been measured 
with an exactitude of 0.01 seconds. The amplitude for upward 
deflections has, as is customary, been measured to the upper 
contour of the base line, for downward deflections to the 
lower contour of the base line. The durations of deflections 
have been measured from the point where the convex or concave 
curvature leaves the contour of the isoelectric line to the 
point where this curve rejoins said contour. 
Measurement of the S-T junction displacement and vol-
tages of the QRS deflections are referred to the level at 
which the first QRS deflection takes off from the P-R segment . 
Ratios are given as they occurred unless one of the ampli-
tudes was 0.5 mm. or less in which case the ratio was calcu-
lated so that all ratios could be compared to 1. P-R inter-
val was measured from the beginning of the P-wave to the 
earliest component of the QRS complex in the lead in which it 
was longest. The QRS interval was measured from the point 
where the first deflection of the QRS group departs from the 
base line to the point at which the last deflection comes to 
rest at the S-T junction. This was measured on several groups 
and an everage taken for each recording. The Q-T interval 
was measured from the beginning of the QRS complex to the end 
of the T-wave in that lead in which the end points were most 
clearly defined, and in which the largest value was found. 
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A 3 - channel physiographl was used to record the phono -
cardiogram and to monitor any changes in the heart sounds of 
those dogs used in the valvular insufficiency part of this 
project. Phonocardiograms of dogs were r ecor ded once or twice 
presurgically and at various intervals following surgery. In 
addition all dogs were examined periodically by ausultation 
and palpation to determine the course of their condition . 
D. Surgery 
1. General considerations 
Three types of cardiac pathology were produced by 
surgical methods. In each case other dogs were sham-operated 
performing the same procedures e::cept for production of the 
actual pathological process. A total off ifty animals had 
surgery performed; however, nine of thtse died during surgery 
or shortly after before all phases of the project could be 
completed. 
All materials which were used in the surgica l procedures 
were sterilized by one of two methods. Steam sterilization 
under pressure was used for surgical instruments , gloves, 
linens, vetafil2 and silicone rubber tubing3 . Chemical 
1E and M Instrument Co., 5815 Sidney St., Houston, Texas . 
2 Fort Dodge Laboratories, Synthetic nonabsorbable sutur-
ing. Fort Dodge, Iowa . 
3sila tube - Ronthor Reiss Corp. , Ronsil Products Division, 
Little Falls, New Jersey. 
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disinfection by immersion in aqueous 0.02 percent chlor-
hexidine1 provided the means for disinfecting materials with 
low heat tolerance and instruments with sharp cutting edges 
which become dulled by repeated autoclaving. 
Anesthetization of the dogs used in surgical procedures 
was accomplished by the intravenous administration of sodium 
pentobarbital solution given to effect. The dose was approx-
imately JO milligrams per kilogram body weight. Solid food 
was withheld for at least 12 hours prior to surgery. Hair 
over and adjacent to the surgical field was removed by using 
an electric clipper with a No. 40 blade. The skin was then 
prepared for surgery by repeated scrubbings with a 25 percent 
aqueous germicidal detergant which contained o.6 percent 
benzethoniwn chloride2• The lather was removed with cotton 
after each scrubbing. An endot.·acheal catheter with cuff 
was inserted into the trachea and the cuff was inflated. 
The tube was then taped to the upper jaw to prevent 
accidental dislodgment. The catheter was attached to an 
artificial respirator ap~ratus3 if thoracic surgery was to 
be performed and the oxygen pressure was set for 11 to l4 
centimeters of water. 
lNolvasan. - Fort Dodge Laboratories, Fort Dodge, Iowa. 
2aermicidal Detergent. Parke, Davis and Co., Detroit, 
Michigan. 
3pR-J Prothoracic Respirator with breathing bag. Profes- -
sional Veterinary Service, $19 SW 12th Ave., Miami, Florida. 
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The hands and arms of the surgeon were repeatedly 
scrubbed with the 25 percent aqueous germicidal detergent 
and then rinsed with tap water. After completing the scrub-
bing, the surgeon dried his hands and arms with a sterile 
towel and donned a sterile, full-length operating gown. He 
then put on dry, sterile surgical gloves. 
The animal was then draped with sterile cloths leaving 
the surgical field exposed. Adjacent areas of hair and skin 
were securely covered. 
There are four principles of good surgical techniques 
which, if observed, enhance the chance for successful results. 
These principles are devoted to minimizing undesirable 
sequalae to tissue injury (27). 
These principles are first, aseptic technique, or pre-
venting the introduction of infectious organisms into the 
field of surgery. This is accomplished by using sterile 
equipment and avoiding contamination. The second is atrau-
matic technique, or minimizing unnecessary devitalization of 
tissue. The third requirement is hemostasis or the control 
of hemorrhage to prevent shock. Finally, the last require-
ment is careful closure of exposed ti ssues. This is achieved 
by accurate apposition of divided parts and by meticulous 
suturing technique. 
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2. Myocardial infarction 
The production of experimental myocardial infarction was 
accomplished in two stages. Preliminary trials by the author 
and Cholvin1 indicated that the procedure described below is 
very satisfactory. 
The procedure was made on 14 dogs and consisted of two 
stages. The first stage involved thoracic surgery. The thor-
ax was entered from the left side at the fourth or fifth 
intercostal space depending on whether the anterior or pos-
terior left descending coronary artery was to be ligated. An 
incision was made through the skin from 2 to 3 cm. above the 
point of the scapula, depending on the size of the dog, ex-
tending ventrally to within 2 to 3 cm. of the ventral midline. 
The incision was continued through the subcutaneous tissue and 
the muscular tissue: latissimus dorsi, superficial pectoral, 
serratus ventralis, and intercostal muscles. The parietal 
pleura was carefully penetrated with scissors and cut the 
full length of the incision. The ribs were spread by self-
retaining rib retractors and the lungs were pa.eked off with 
sterile-saline-soaked or blood-soaked-swabs. This procedure 
was followed in all thoracic surgery. The pericardial sac 
was incised parallel to and approximately 1 cm. ventral to 
1cholvin, N. R. N. I. H. Research Fellow -.Departme~t 
of Physiology and Pharmacology, College of Veterinary Medi-
cine, Iowa State University, Aines, Iowa. Now Department o~ 
Medicine and Surgery, College of Veterinary Medicine, Michi-
gan State University, East Lansing, Michigan. 
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the phrenic nerve and fixed to the body wall by means of two 
or three strategically located stay sutures . A piece of 
vetafil ligature was then placed around either the anterior 
or posterior left descending coronary artery or some large 
branch of the anterior artery at various levels. One throw 
was placed in the ligature thus enclosing the artery in a 
loo se knot . The ends of the ligature were then threaded 
through two , 3-5 inch pieces of silicone rubber tubing . This 
material was used because of the report that it caused very 
little tissue reaction (27 ). The pericardial sac was sutured 
with vetafil incorporating the tips of the silicone tubing 
within the sacs. These were fixed in place by a purse-
string suture around the tubes and thr0ugh the sac. The 
pleura and ribs were brought together and suturej with inter-
r upted vetafil ligatur es . The silicone tube~ with the veta -
fil ligature within were incorporated within the body wall, one 
arising near the top of the rib and the other near the bottom 
of the ribs . The tubes were sutured in place at the junction of 
the ribs with a purse-string suture . The ends of the vetafil 
ligatures were brought through the extending end of the sili-
cone rubber tube with a straight needle and tied leaving a loop 
of excess vetafil. The pleura and muscle layers were brought 
into apposition and sutured with cont inuous catgut. The 
tubes were laid down upon the muscles lying subcutaneously 
and one stay suture affixed. The subcutaneous tissues 
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were sutured with interrupted catgut and the skin closed with 
simple interrupted vetafil sutures. The same suturing tech-
niques were used throughout each surgical procedure with re-
spect to closing the pericardium, thorax, muscles, subcutaneous 
tissues, and skin. 
In preliminary work the vetafil ligatures were brought 
out together to lie subcutaneously. This often resulted in 
the vetafil becoming adhered to tissues so that the ligature 
could not be tightened down and the angle for tightening the 
ligature was very poor and occasionally resulted in rupturing 
the artery. 
The animal was allowed to recover for six to eight days 
at which time it wa~ again anesthetized and prepared for 
surgery. A small incision was made over each of the silicone 
tubes and they were brought to the surface. The vetaf'il 
ligatures were isolated, pulled taut to ligate the vessel and 
the ends tied together tightly. The subcutaneous tissues 
were sutured as were the incisions in the skin. In some 
cases the silicone tubes were removed; in others, they were 
left in place. The vetafil was cut as close to the skin as 
possible at top and bottom 20 to 30 minutes later. 
The first post surgical ECG was taken at one hour and the 
second at two hours. Further recordings were made at various 
intervals. Serum samples were collected every 6 to 10 hours 
for three to four days starting at 10 to 15 hours post-
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surgery and then at various intervals until the dog was 
sacrified. Hematological studies were made at various inter-
vals commencing at 4 days to one week post surgery. 
Eight sham-operated animals were handled in exactly the 
same manner except the vetafil ligature was merely passed 
under the artery with no knot and the amount of tension 
placed on the ligature was not as great as that put on the 
dogs in which an infarction was later produced. 
3. Epicarditis 
The production of epicarditis was also accomplished in 
two stages in six dogs. In this case the thorax was entered 
at the right fourth intercostal space in the region of the 
cardiac notch. The first step involved the placing of a sili-
cone rubber tube into the pericardia! sac through a very small 
incision in the sac. The tube was sutured in place within 
the sac with a purse-string vetafil suture. The tube was then 
brought to lie subcutaneously in the same manner as that des-
cribed for the infarction dogs. 
Six to ten days later the tube was isolated while the 
dog was under anesthesia and 10 ml. of a sterile talc sus-
pension were deposited within the pericardialsac. The end 
of the tube was closed with a piece of rubber tubing and a 
vetafi l ligature . The tube was fixed in place subcutan-
eously and the tissues sutured. ECG recordings were taken at 
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various intervals following surgery as were serum and blood 
samples. Three dogs were sham-operated in precisely the 
same manner except for the deposition of sterile talc. 
4. Valvular insufficiency 
In preliminary trials an attempt at producing valvular 
insufficiency via venous catherization was made. However, 
without the aid of a fluoroscope and because of the incon-
sistency of the damage produced, this technique was abandoned. 
A second method as described by Markowitz ~ 2].. (98) by 
sectioning the chordae tendinae was used, but after problems 
with .fibrillation and failure to produce clinically obvious 
pathology, this method was also abandoned. 
A technique described for the removal of heart , worms 
(Dirofilaria immitis) (157) was modified by the author and 
Cholvin1 and used to produce valvular insufficiency in five 
dogs . An incision was made over either the right or left 
fourth intercostal space depending on whether a left or a 
right A-V valvular insufficiency was being produced. Dogs 
were atropinized at the rate of .02 grain for average-sized 
dogs. Once inside the thoracic cavity a 15-inch piece of 
1/8 inch wide umbilical tape was passed around the anterior 
vena cava. This was much easier from the right side approach 
than from the left. The free ends were passed through a 
1Ibid. page 56. 
I 
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3-inch section of 3/16 inch rubber tubing. The posterior 
vena cava was similarly exposed and prepared for occlusion. 
The pericardium was then incised approximately 1 cm. ventral 
to the phrenic nerve and parallel with it and extending from 
the anterior to the posterior extremities of the sac. The 
sac was retracted dorsally and ventrally lifting the heart up 
and held in place with stay sutures. The placement of stay 
sutures varied depending upon which method presented the sur-
face of the atrium best for the surgical procedure. Two, 
12-inch pieces of vetafil suture were passed through the 
atrium 3 to 4 cm. apart with an atraumatic needle. These 
were used to apply tension to the atrium to attach the non-
1 crushing clamp. The clamp was then applied to the atrium 
while lifting it up with the vetafil sutures as far away from 
the auricle as possible. A 2 to 3 cm. incision was made in 
the atrium in the clamped tissue. The venous flow through 
the posterior vena cava was interrupted by applying tension 
to the ends of the umbilical tape and forcing the rubber 
tubing against the vessel. This tension was maintained by 
applying hemostatic forceps on the umbilical tape at the 
distal end of the rubber tubing . The anterior vena cava was 
similarly occluded. The blood supply from the brain was 
never occluded for more than 2 1/2 minutes. The clamp was 
lsatinsky Vena Cava Clamp. J. Sklar Mfg. Co. J S-04 
Woodside Ave., Long Island City 4, New York. 
62 
removed by an assistant who at the same time applied mild 
tension to the vetafil suture in the atrium. The surgeon then 
used a spay book to pick up the chordae tendinae and the 
amount of damage desired is made with a scalpel on the cusps 
of the valve. A hook with an inside cutting edge may also be 
used but it is more difficult to control the amount of damage. 
The valve was then released and the clamp was applied 
under the tension sutures while the assistant applied tension 
to them. The hemostats on the umbilical tape were released 
thus restoring the patency of the vessels. The amount of 
regurgitation can be fairly well ascertained at this time. 
If more damage is desired, the process can be repeated after 
several minutes. 
The incision was sutured with 5-0 black braided cardio-
vascular silk with a swaged atraumatic needle. 1 One row of 
simple continuous was made. The assistant applied tension to 
the stay sutures and the clamps were released to allow a 
slight amount of hemorrhage. Then a second row of simple 
continuous suture was continued back over the first, making 
sure to place the needle between sutures already present. 
The clamps were then removed and the area checked for signs 
of hemorrhage. If no hemorrhage occurred the stay sutures 
were removed and the pericardia l sac and thorax were closed 
lK-$70 A Cardiovascular s i lk - Ethicon, Inc., Somerville, 
New Jersey. 
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as described previously. If some hemorrhage occurred which 
did not cease shortly, several interrupted matress sutures 
were applied. This procedure allowed a very minimal amount 
of blood loss and provided a method where the amount of in-
sufficiency produced could be well controlled and failure to 
produce damage was almost impossible. 
One left A-V valvular insufficiency and four right A-V 
valvular insui'ficiencies were produced in this manner. Five 
dogs were sham-operated. All procedures were the same except 
for production of valvular damage. Two of these were ap-
proached from the left and the other three from the right. 
E. Postsurgica l Care 
Care of dogs following surgery was intentionally kept 
to a minimum except for routine examinations. Immediately 
following surgery the air was aspirated from the pleural 
cavity so that the lungs would assume their normal functioning 
rapidly and lack of oxygen would not be an additional stress 
factor. Antibiotics were not used routinely following surgery 
and bandaging was found not to be necessary. Each animal was 
examined daily for the first 7 to 10 days and then at 2 to 4 
day intervals. Only two animals developed an infection in the 
surgical incision, both of them were cured shortly with anti-
biotic therapy. No cardiac drugs were given to any of the 
dogs. They were not exercised, but remained in a cage at all 
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times except for bleeding and taking ECG and phonocardiogram 
recordings. 
One dog in the valvular insufficiency group was admin-
istered a diuretic and was treated for anasarca by surgical 
drainage several times. Other treatments were merely routine. 
F. Necropsy and Histopathology 
Dogs were sacrificed and necropsied at various times 
following the production of pathology. Necropsy procedure as 
outlined by Coffin was followed (28). Following gross post-
mortem examination, a descriptive protocol was written and, 
where appropriate, photographs of the lesion were taken. 
Representative portions of tissues from lesionsw&re selected 
and fixed in 10 percent buffered f~rmalin (4 percent formal-
dehyde solution) for histological examination. Tissue Jamples 
were taken routinely_from the heart, liver, kidney and spleen. 
Other tissues were taken if a part appeared abnonnal grossly, 
including tumorous-like growths. 
Tissues were processed in the usual manner and the sec-
tions stained with hematoxyin and eosin. In a few cases a 
connective tissue (Mallory Triple Stain) stain was used to 
show a greater contrast between normal and abnormal tissues. 
Samples for microbiological examination were not taken 
routinely. However, in three cases of epicarditis which were 
cultured there was no growth seen on blood agar. 
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IV. RESULTS AND DISCUSSION 
A. Hematological Studies 
Dogs were given a routine hematological examination as 
they were obtained for experimentation. Table 5 is a summary 
of the presurgical hematological data of 50 normal dogs used 
in this research project. 
Table 5. Pretreatment hematologic data from 50 normal dogs 
Hemoglobin 
Hematogrit 
RBC 10 
WBC 103 
Differential WBC (~~ ) 
Mature Neutroph:a..ls 
Immature Neucrophils 
Eosinophils 
Basophils 
Lymphocytes 
Monocytes 
Average 
16.5 
45.5 
7.1 
12.0 
70.0 
3.0 
3.5 
.5 
19.0 
4.0 
Range 
(12.3-19.4) gm/100 ml. 
(36-55) percent 
(4. 5-8. 7) cu. mm. 
(6.l-22.2) cu. mm. 
(51-90) 
(0-10) 
(0-13} 
(0-4) 
(7-34) 
( 0-15) 
Hematological studies are of utmost importance in any 
physiological study as well as in any clinical study. There-
fore, blood samples from each dog were studied at intervals 
to follow any possible changes occurring in the blood picture. 
Since dogs were sacrificed at various intervals throughout 
the research , some dogs were studied only once postsurgically 
while others were studied several times over periods of up 
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to 45 weeks. Generally, speaking, infarction dogs were 
sacrificed from 1 to 4 weeks following surgery whereas the 
epicarditis and valcular insufficiency dogs were kept for much 
longer periods. 
Serial hematological data are shown in the appendix for 
all dogs arranged in groups as to type of operation performad. 
Very little can be said as to any constant changes which 
occurred in the hematology of the dogs undergoing surgery. 
All dogs stayed within normal limits in hemoglobin, hemato-
crit, and total erythrocyte count. Most dogs remained withi n 
normal ranges in total leukocyte and differential leukocyte 
counts; however, epicarditis dogs generally had elevated 
leukocyte counts early in the syndrome (not seen in shams) 
wr.ich returned to lower regions after several weeks. The 
only other general trend noted was in the valvular insuf-
ficiency dogs where a higher eosinophil count was present 
following surgery. It was thought that this might be due to 
a reaction to the silk foreign body in the atrium; however, 
this could not be confirmed on histological study of the 
area involved. 
It can be said generally that hematological studies are 
of little aid in determining the presence or extent of lesions 
of the heart in the three conditions produced when strict 
asepsis was practiced as done in this research. 
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B. Normal Serum Enzyme Activity Assay Methods 
and Factors Involved 
As dogs were selected for surgery, serum samples were 
collected for GOT, GPr, and LDH determinations. These pre-
surgical values are within the normal range and compare very 
well with those previously reported (31, 32, 116, 144). 
Table 6 is a summary of the presurgical serum enzyme activity. 
At least one other presurgical determination was made on 
each dog and occasionally as many as three different pre-
surgical samples were analyzed. These varied as much as 10 
units on SGOT and SGPT and up to 200 units on SLDH. However, 
all determinations were within the normal ranges set by 
original samples. 
Table 6. Pretreatment serum enzyme values (Karmen Units) 
Transaminase (50 dogs) SLDH (22 dogs) 
~GOI ~QfI 
Met hog Method Method 
H~rgt Sims Sig;inS& Sigma 
Average 24.6 24.2 21.2 220.7 
Range 18-37 12-53 12-36 45-455 
The Sigma method (145), which is a commonly used 
clinical method for SGOT, was compared for accuracy with the 
method of Hergt and Langin (64). It was found that there 
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was no significant difference between the two methods when 
SGOT was within normal range. In addition, the reproducibility 
of the two methods was studied. Both methods showed no sig-
nificant difference in reproducibility; however, the Hergt 
method was more variable and approached the 5 percent sig-
nificance level in variability. Tables 7 and 9 present the 
details of this study. 
Table 7. Comparison of Hergt and Sigma methods on dupli-
cate SGOT determinati ons 
Average difference 
Range of difference 
Method 
1.0 
-8.0 to 5.0 
Sie;ma 
1.0 
-6.0 to 4.0 
No significant differences in either method on re-
peatability. 
Hergt method is approaching 5 percent significance 
level on variability. 
Since it had been reported that repeated freezing and 
thawing decrease serum enzyme activity, samples were frozen, 
thawed, assayed and refrozen, thawed and assayed again a few 
days to a few weeks later. Table 8 shows the results of 
this study. It was found that there was a significant loss 
of activity at the l percent level with the Sigma method and 
at the 5 percent level, approaching the 1 percent level, with 
the Hergt method. 
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Table $. Comparison of samples analyzed after a second 
freezing and thawing on duplicate SGOT deter-
minations 
Method 
Average difference 
Range of differences 
Hergt 
2.4 
o to -8••• 
Sigma 
2.3 
O to -6••• 
••significant at 5 percent level approaching the 1 
percent level. 
•••significant at 1 percent level that there is a 
loss of activity. 
Table 9. Comparison of Hergt vs Sigma method at various 
SGOT concentrations 
SGOT Concentration {unit§} 
15 3~ 4J - 6g• 20 L, Jo• 
Hergt Sigma Hergt Sigma Hergt Sigma 
Average 25.6 24.6 4g.8 51.8 159.1 202.4 
Range 18-38 17-38 40-62 41-69 70-320 75-410 
*Significant at the .1 percent level. 
In comparing the Hergt method with the Sigma method at 
increased serum enzyme concentrations, it was found that 
there was a significant difference between the two methods 
at the 0.1 percent level (See Table 9, and Figures l and 2). 
However, since neither method could be compared with a known 
concentrat ion of enzyme , it is impossible to say which method 
.. . 
Figure l. Graphic representation of SGOT levels of 
selected dogs following myocardial infarction 
(Sigma method). 
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Figure 2. Graphic representation of SGOT levels of 
selected dogs following myocardial infarction 
( Hergt method). 
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is the most accurate at these increased concentrations. It 
is thought that the Sigma method is the more advantageous be-
cause it spreads out the range of activities, thus separating 
abnormally high activities from the normal low activities. 
Since it was reported by Ranke §! 2,l. (126) that there 
may be a difference in serum enzyme concentration in human 
subjects with age, dogs which were divided into three age 
groups for ECG purposes were analyzed as to serum enzyme con-
centration from presurgical data. Table 10 is a compilation 
of the results. It was found there was no significant dif • 
ference in serum enzyme activity due to age differences, and 
age was not considered as a factor in further studies. 
Table 10. Normal serum enzyme levels arranged as to agea 
(Sigma method) 
Age No. SGOTb SGPTb No. SLDHb 
dogs dogs 
1 11 22.1 21.4 8 160.6 
(12-28) (13-30) (70-325) 
2 28 25.8 21.2 12 260.4 
(13-53) (12-35) (140-455) 
11 21.6 21.1 4 136.2 
(14-30) (16-36) (45-200) 
aAge differences are not significant statistically. 
bAverage and range. 
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c. Surgery and Associated Factors 
As described previously, three types of cardiac pathology 
were produced by surgical methods. Each surgical procedure 
was followed by serial enzyme and ECG studies. All dogs were 
necropsied and gross and histopathological studies were made 
of organs and tissues. Each of these studies will be discus-
sed under separate headings. Table 11 is a summary of 
surgery performed. 
Table 11. Swnmary of experiment al surgery 
No. No. No. 
Procedure O:eerated Lived Necro£sieg 
Infarction 17 14 17 
Sham g 8 g 
Vulvular insufficiency 11 5 11 
Sham 5 5 5 
Epicarditis 6 6 6 
Sham 3 3 3 
TOTALS 50 41 50 
D. Serial Enzyme Studies Following Surgery 
l. Myocardial infarction studies 
Seventeen dogs underwent surgery to produce myocardial 
infarction. Two of these dogs did not survive surgery and one 
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died 10 hours after production of myocardial infarction. 
Fourteen dogs had various degrees of myocardial infarction 
produced. Table 12 is a summary of enzyme activity presur-
gically and peaks reached. 
Eight dogs were sham-operated. All dogs lived and serial 
enzyme activity determinations were made for three to four 
weeks. Table 13 is a summary of enzyme activity presurgi-
cally and peaks reached. 
One dog, No. 25, had two infarctions produced. While 
attempting to put a ligature around the anterior left des-
cending coronary artery, it was accidentally punctured. The 
artery had to be ligated to stop the hemorrhage. Several 
weeks later the dog underwent surgery again and a second in-
farct was produced by ligating the left posterior descending 
coronary artery {See Figure 14, Appendix B). Upon necropsy 
one dog, No. 38, was found to have an accompanying epi-
carditis. 
The serial serum enzyme studies indicate that activity 
starts to increase at 8 to 15 hours following infarction. 
Peaks are reached at 18 to 24 hours with SGOT and SGPT at 
25 to 30 hours with SLDH. It has been reported (60, 85, 
132), as described previously, that SGPT does not .rise to 
any significant level in myocardial infarction of humans. 
However, it was repor ted (132) that SGPT may rise following 
myocardial infarction in the do gs. Cornelius (31) feels 
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Table 12. Enzyme levels of infarction dogs (Karmen units) 
~1'02!.1 
Herft 
SGOT :U.. )a SGOT(l4) SiaPa SQPT(J4) LDHC9) 
Pre surgery I 
average 23.5 23.4 22.8 242 
range· 19-32 14-37 17-36 130-450 
Pre surgery II 
average 25.2 22.4 21.0 283 ( 5) 
range 20-38 13-32 18-25 170-500 
Range of peaksb 40-320 49-410 21-240 280-1225 
aNumber of dogs in parenthesis. 
bBegan to elevate from 8-18 hours post surgery. 
Transaminase reach peak in 12-31 hours and LDH, 5-10 hours 
later usually. Transaminase remain elevated for 25-60 hours, 
LDH, 10-20 hours longer • 
Table 13. Enzyme levels of sham infarction dogs (Karmen 
units) 
Presurgery I 
average 
range 
Presurgery II 
Sao Ta 
22.9 
18-27 
average 22.9 
range 20-26 
Range of peaksb 26-41 
Method 
SGOT(S) 
22.2 
18-27 
26.1 
21-JO 
25-43 
aNumber of dogs in parenthesis. 
19.5 
12-26 
22.l 
15-40 
18-39 
257 
205-325 
130-280 
bTime to reach peaks varied from 14 to 61 hours -- all 
:~turned to normal shortly after peak was reached and con-
~inued within normal ranges. 
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that elevated SGPT in dogs :is · indicative of liver necrosi·s · 
alone. The results from this research indicate that SGPT may 
rise to high levels but not as high a level as SGOT (Figures 
1, 2 and 3). This fact must be kept in mind when suspecting 
liver damage because of the high SGPT values, the heart could 
be involved instead of the liver • From the reports of other 
workers it would seem that the time-concentration curve would 
be more prolonged in cases of liver pathology than in those 
involving the myocardium. In addition, the increased SGPT 
activity will be nearly as high as, or higher than SGOT in 
necrosis of the liver. 
This work indicates that SLDH is not as reliable as 
SGOT as an index of myocardial necrosis (Table 12 and Figure 
4). Results are erratic (See Table 27, Appendix A) and be-
cause of the wide range of normal values, it was frequently 
impossible to confirm a diagnosis of myocardial infarction 
with this enzyme assay, 1.~., although the serum activity 
might be increased several times the normal value for the 
particular dog involved, it often falls within what must be 
considered the normal range. This presents a real problem in 
clinical work where the clinician seldom has a "normal" for 
the dog presented. 
SGOT and SGPT levels remained elevated for 40 to SO hours 
depending somewhat on the amount of necrosis present, i.~., 
Figure 3. Graphic representation of SGPT levels of 
selected dogs following myocardial infarc-
tion. 
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Figure 4. Graphic repr esentation of SLDH levels of 
selected dogs following myocardial infarction. 
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as the amount of infarcted tissue is increased the peak 
concentrations are higher, and the length of time the enzyme 
remains elevated is prolonged (See Table 14). However, this 
is still a relatively short period since frequently the 
patient may not be presented to the clinic until three to 
four days after the onset of symptoms. It is reported (46 , 
72, 161) that SLDH levels remain elevated for longer periods 
(six days) in humans. It was found in this work that SLDH 
activity remained at abnormally high levels in dogs with myo-
cardial infarction for 10 to 20 hours longer than the 
transaminases. Figures 1, 2, 3, and 4 depict the changes 
in enzyme concentrations in dogs suffering from various 
amounts of infarction. (See Tables 25 through 27, Appendix 
A for serial enzyme changes of each dog with myocardial in-
farction.) 
Once the enzyme returns to the normal range there was 
seldom any marked elevation of the serum levels again in 
these studies. However, one dog, No. 11, did show a rise 
several weeks after production of an infarct. Upon necropsy, 
two small infarcted areas were found, one where the ligature 
had been placed and one more posteriorly on the endocardial 
surface of the left ventricle . It is thought that the 
second rise was due to this infarct; however, the dog did 
not show any outstanding symptoms at this time. This will 
be discussed in more detail later. 
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Infarcts were measured at the time of necropsy and these 
were correlated with the SGOT elevations. Table 14 gives the 
results. The results compare very favorably with the reports 
of other workers where tissue enzyme analyses were compared 
from necrotic areas and coITelated with serum concentration. 
As a matter of interest SGPT was also correlated with amount 
of necrosis found at necropsy {Table 15). From this table it 
appears that only the more severe infarcts result in a great 
increase in SGPT and this may partially explain the contro-
versy appearing in the literature regarding the elevation of 
SGPT in myocardial infarction. One can be misled by measur-
ing only the diameter of the lesion since the depth of the 
infarcted area is not considered. In general the total 
amount of infarcted tissue correlated very well with the rise 
in SGOT. Individual dog serial SGOT and SGPT relating to 
amount of infarction are presented in Tables 25 and 26 
(Appendix A).-
As can be seen from Table 13 most of the sham-operated 
dogs remained well within normal serum enzyme ranges fol-
lowing surgery. However, a few animals did approach very 
high normal values or low abnonnal values (40 units or over). 
Individual serial levels for the first 90 hours following 
surgery are shown in Table 2S (Appendix A) for sham-operated 
dogs . Serum levels continued within normal ranges until 
Table 14. Comparison of presurgical and postsurgical SGOT levels of dogs with 
myocardial infarction (Sigma) 
No. Dia. Pre- Hours ~ostsurgerI 
dog§ inf. ~liu:g. lZ - ~2 22 - ~z 2 - 2~ 22 - ~1 ~2 - 20 21 - 72 
4 < l cm. 20.5 63.5 59.0 45.5 39.2 34.0 32.0 
(18-22} (48-75) (45-64) (39-57) (35-51) ( 30-42) ( 30-35) 
3 1-2 cm. 27.7 150.3 108.3 105.7 78.3 51.0 39.3 
(18-37) (121-170) (88-140) (82-130) (50-118) ( 30-75) (29-50) 
7 > 2 em. 23.l 277.1 236.6 139.7 69.9 64.7 38.6 
(14-32) ( 80-400) (118-410) (72-280) (45-150) (40-130) (25-65) 
Table 15. Comparison of presurgical and postsurgical SGPT leveJsof dogs with ~ VI 
myocardial infarction 
No. Dia. Pre- Hour§ 2ostsurgerI 
dogs inf 1 surg 1 lZ - 22 2J - 2z 28 - l~ J2 - li:J ~~ - 20 21 - z2 
4 < 1 cm. 24. 5 
(17-36) 
38.5 
(24-48) 
39.2 
(29-48) 
34.2 36.2 36.2 29.5 
(20-42) (23-41) ( 31-46) ( 20-40) 
3 1-2 cm. 26.0 34.3 33.7 33.3 . 34. 7 30.7 23.3 
(20-JO) (25-44) ( 27-42) (28-39) (29-38) (25-36) (20-28) 
7 >2 cm. 20.4 
(17-24} 
125.9 118.9 
(60-240) (55-220) 
110.4 
(65-220) 
105.l 
(69-171) 
83.l 
(55-139) 
46.7 
( 29-64) 
I .. 
~ . 
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sacrifice. Figure 5 depicts the levels of each of the enzymes 
at various times following surgery. 
The exact reason for the small elevation occurring has 
not been determined. It may be just coincident with a normal 
physio·logical elevation, but more likely it is from damage 
to skeletal muscles which occurred on two or three occasions 
in attempting to isolate ligatures. However, this does not 
seem quite logical since transaminase activities following 
thoracic surgery were seldom over 100 units GOT and then much 
more skeletal muscle was damaged. A third possibility could 
be some liver damage following the repeated use of sodium 
pentobarbital, however, here again, it seems the liver could 
tolerate the anesthetic dose without causing any harm. Per-
haps it is a combination of these and other factors. Since 
much of the physiology involved is not understood at this 
time , the answer will have to remain speculative for the 
present. 
Serum GOT and GPT concentrations can be a definite 
aid to the diagnosis of myocardial infarction in dogs. More 
work needs to be done with SLDH before it is valuable in the 
diagnosis of myocardial infarctions in dogs. 
2. Epicarditis studies 
Nine dogs have been included in this group. Of these, 
three were sham-operated. Table 16 presents presurgical 
data as well as postsurgical averages on dogs with pathology 
Figure 5. Graphic representation of enzyme levels of 
selected sham-operated myocardial infarction 
dogs (Sigma). 
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produced. All but one dog remained well within normal range. 
This dog, No. 10, presented an increase in both SGOT and 
SGPT of 48 and 37 units, respectively, four months after 
surgery. This was apparently a transient rise which had dis-
appeared when another serum sample was taken two weeks later. 
No pathology which could account for this rise was found upon 
necropsy four weeks later. Dog 43 showed a progressive rise 
in SLDH from a presurgical value of 200 units up to 555 units 
at 5 weeks. This level then declined gradually back to 255 
units at 4 months. The reason for this rise is hot known, 
but is believed to be a result of the natural variation of 
the normal levels and of the test. Individual serial enzyme 
data are shovm in Table 29 (hppendix A). 
Table 16. Enzyme levels of dogs with epicarditis (Karmen 
units) 
Method 
Hef~~ SGOT a SGOT(6} Sig;na SGPT(6) SLDH{2} 
Pre surgery I 
average 22 .7 24.7 18.8 
range 18-29 14-33 13-23 120-200 
Pre surgery II 
average 28.0 25.0 20.5 
range 22-31 16-30 16-27 125-130 
Postsurgeryb 
26.6 26.0 22.9 246 (4) average 
range 18-44 13-48 12-37 100-555 
aNumber of dogs in parenthesis. 
bAverage for samples taken at intervals for three 
months or more. 
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Data from sham-operated dogs appeared to be well within 
normal ranges for the three enzymes upon serial study. 
Table 17 shows presurgical and postsurgical averages and 
ranges. Individual serial enzyme data are shown in Table 30 
(Appendix A). 
From this study it can be concluded, concurring with 
the reports of other workers, that serum enzyme levels are 
of little value in diagnosing an epicarditis and peri-
carditis. However, they might be an important negative 
finding when considered in conjunction with clinical symptoms 
and ECG rec.ordings. Figures 6 and 7 depict serial enzyme 
levels in epicarditis dogs and shams. 
Table 17. Enzyme levels of sham-operated dogs for 
epicarditis (Karmen units) 
Method 
He:r:T~ SGOT)a SGOT(3} Si~ma SGPT(3) LDH(2) 
Pre surgery I 
average 23.0 19.3 19.7 
range 20-27 18-21 16-23 75-150 
Pre surgery II 
average 20.7 18.3 19.0 
range 16-26 16-20 18-20 75-130 
Postsurgeryb 
average 25.1 23.8 19.9 124 
range 14-36 14-36 14-30 75-225 
a Number of dogs in parenthesis. 
bAverage for 
months or longer. 
samples taken at intervals for three 
Figure 6. Graphic representation of serial enzyme levels 
of selected epicarditis dogs (Sigma). 
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Figure 7. Graphic represent~.tion of serial enzyme levels 
of selected sham-operated epicarditis dogs 
(Sigma). 
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3. Valvular insufficiency studies 
Sixteen dogs had surgery. Five of them were sham-
operated. Four dogs had a right A-V valvular insufficiency 
produced and one a left A-V valvular insufficiency. The 
rest died during surgery or shortly after from a variety of 
causes. All dogs were necropsied and varying grades of 
pathology observed in the dogs with lesions produced. These 
lesions will be described in more qetail later. Dog 42 
showed the greatest amount of damage. This dog had shown 
severe symptoms from the pathology and succumbed 72 days 
following surgery from excessive fluids in the pleural 
cavity. Table 1$ summarizes the results of the serial enzyme 
study. Figure 8 depicts the serial studies after the fourth 
day when enzyme levels returned to near normal following the 
I 
surgical procedure. Table 31 (Appendix A) shows serial 
studies of individual dogs through 12 weeks. 
All dogs returned to normal following surgery and re-
mained at normal levels for several weeks. There was then a 
trend to a slight increase in enzyme levels; however, for the 
most part these stayed within normal ranges. Dogs 41 and 42 
showed a rise in SGOT and SGPT over a period of about two 
weeks which were definitely elevated beyond normal levels. 
In both cases SGPT rose to higher levels than SGOT. The 
sampling at this time was at two-week intervals so no time-
concentration curve was made. Still, it seems reasonable to 
.-
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expect that some liver damage was occurring from the passive 
hyperemia. This theory was confirmed upon necropsy when 
histological and gross studies indicated necrosis of the 
liver. However, this damage apparently was not severe enough 
to cause clinical symptoms over and above those of the 
cardiac pathology. 
Table 18. Enzyme levels of valvular insufficiency dogs 
{Karmen units) 
METHOD 
Herf t 
SGOT 5)a SGOT(5) 
Sigma 
SGPT(5) LDH(4} 
Pre surgery 
21.8 average 29.2 25.0 231.2 
range 24-34 18-34 15-31 45-455 
Peak 
average 120.8 139.8 56.6 421.8 
range 75-215 80-230 23-115 177-590 
Time to peak 
hours lh-21 17-25 17-21 25-50 
Time to normal 
hours 55-100 55-100 50-90 60-100 
aNumber of dogs in parenthesis. 
bnogs returning to normal remained within normal 
range except dogs 41 and 42. 
Table 19 is a summary of the sham-operated dogs. Re -
sults were very similar to t hose s een in the dogs with 
l esions produced. However, once dogs returned to normal 
serum level s they continued within no rmal r anges . The serum 
l evel s of all three enzymes r emained quite s t able throughout 
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the research. Dog 4 remained in the doubtful zone of 40 to 
60 SGOT units throughout the rest of his life; however, this 
dog had a high presurgical level of 53 units. This points 
out the fact that certain animals may have normal levels in 
what could be considered indicative of pathology in the 
majority of cases. Hence, the clinician must consider the 
overall clinical picture very carefully in those dogs showing 
serum levels between 40 to 60 units. It is fairly safe to 
assume that anything below 35 is normal. Figure 9 indicates 
serial enzyme changes in representative sham-operated dogs. 
Individual serial serum enzyme activity up to eight weeks is 
given in Table 32 (Appendix A). 
Table 19. 
Pre surgery 
average 
ragge 
Peak 
average 
range 
Enzyme levels of dogs sham-operated for valvular 
insufficiency (Karmen units) 
Method 
Her~t 
SGOT{ )a SGbT(5) 
Si1rra SGPT) LDH(2J 
24.6 22.4 1S5 31.2 
lS-30 20-53 17-32 160-210 
43.6 260 119.0 119.6 
56-178 42-232 18-70 230-550 
aNumber of dogs in parenthesis. 
bpeak at 17-27 hours. Peaks are usually a few hours 
later in GPT and 10-25 hours later in LDH. Shams return 
to normal in 50-100 hours and continue within normal range . 
Figure 8. Graphic representation of serial enz~e 
of valvular insufficiency dogs (Sigma). 
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From this study it can be_ concluded that serum enzyme 
levels are of no aid in diagnosing valvular insufficiency. 
However, it must be pointe~ out that liver damag~ may occur 
secondarily to valvular insufficiency and increased SGOT and 
SGPT may follow. Therefore, the clinician must not lose 
sight of the cause and effect relation which occurs in many 
conditions. 
E. Presurgical ECG Data and Factors Involved 
It was found that ECG data could not be analyzed 
statistically with any degree of confidence because of the 
wide variability within any one recording with respect to 
voltage and time. However, measurements were made carefully 
and averages obtained from records of all individual leads 
and these means were used tn further generalizations for 
comparison purposes and for discussion. Presurgical ECG's 
were taken on 46 dogs which were normal, healthy animals and 
in which the ECG appeared to be normal. Since the normal 
ECG in the dog has such a wide variability, certain para-
meters were examined as described previously in the hope of 
finding that factor or combination of factors which could be 
accepted as being nonnal in the greatest majority of re-
cordings. 
Because of the discrepancies reported in the literature 
on electrodardiographic values and the wide variability 
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found on preliminary studies on amplitudes of the various 
complexes from day to day, a ratio was made and this is re-
ported instead of absolute measurements. This ratio in each 
case is compared to R with other values, Q, S, or T, taken as 
1 mm. (O.l mv.). In cases where Q, s, or Tis O, the value 
was omitted in calculating averages. However, these values 
are shown in Tables 33 through 38 (Appendix A). In cases 
where Q, R, or S was less than 1 mm., necessary computations 
were made to compare R to 1 mm. In these cases the relative 
error is quite large due to measuring difficulties and the 
fact that increasing such ratios magnifies error. Tables 20, 
21, and 22 are a compilation of the normal values obtained 
from 46 mongrel dogs of both sexes and all ages. Since age 
had been suggested as being a factor affecting ECG values, 
these data were analyzed statistically for age differences. 
The only significant change was in heart rate which decreased 
with age. 
Table 20. Age effect of dogs on heart rate 
Agea Heart rate 
Group 1 151 (100-175) 
Group 2 141 (100-185) 
Group 3 120 (65-175) 
a Group 1: 4 to 12 months; Group 2: 1 to 5 years; 
Group 3: over 5 years. 
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Presurgical electrocardiographic values are presented 
as standards which is the usual way of reporting such data, 
since it is unwise to break with tradition all together. 
Table 21. Electrocardiographic standards of normal dogs 
(1 mm. :a .1 mv.) 
Lead 
I II III a VF 
Q average 4.15 2.51 1.68 1.46 
range 0.5-12.0 0.5-7.75 0.5-5.25 0.5-5.0 
R average 6.95 19.20 15.78 18.42 
range 1.5-15.0 3.0-33.0 5.0-31.0 8.0-33.0 
S average 1.84 4.42 4.91 5.10 
range 0.25-12.0 0.5-17.0 0.5-16.0 0.5-20.0 
ST+ average .so 1.0$ 1.14 .91 
range 0.5-1.0 -1.25-2.0 -1 5-2 0 -l.0-1.5 • • 
Durations ( secor. is) 
PR QRS QT 
Average .105 .052 .230 
Range .06--.18 .03-.08 .18-.28 
Other workers (71, 86 ) have reported high incidences 
of Qr followed by an inverted T-wave and of Srnfollowed by 
an upright T. The results of this study agree with such 
r eports . It was found that 49 percent of the recordings had 
a QI, 88 percent had an SrII and 60 percent showed a negative 
. ; ; 
. . . 
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T in lead I . A negative T followed a Q-wave in lead I 95 
percent of the recordings and an upright T-wave followed an 
S-wave in l ead III in 89 percent of the r ecords. (See 
Table 23 ). SII and SaVF occurred together in approximately 
90 per.cent of the records . Upward T-waves occurred in 80 to 
90 percent of the records in leads II, III and aVF. Q-waves 
and S-waves occurred most often in lead II and because of 
this it was used f or all further R/Q, R/S, and R/T r atios . 
ST deviation occurred in only 20 percent of all recordings 
but in 46 percent of the dogs in one or more leads. However , 
as can be seen from Table 21 , this deviation was quite small, 
being ± 1 mm. or less in 90 percent of the recordings sho~tlng 
deviation and never over 2. 0 mm. (in two leads ). ST devia-
tion was always up in lead I and was seen in only 25 percent 
of t h e recordings showing deviation, or less than 11 percent 
of a ll dogs, and was always l ess than 1 mm. 
Records taken on separate days presurgically followed 
similar patterns; however, there was a lot of difference in 
absolute amplitudes and some difference in duration of com-
plexes . Ratios, although varying considerably , did not var y 
as much as the absolute amplitudes in R/Q and R/S. However, 
R/T varied about as much as absolute T amplitudes and T also 
varied back and forth fro m positive to negative in a ll leads ; 
however, there was a trend t o continue as positive in most 
i nstances in l ead II , III and aVF. This same pattern was 
seen in sham-oper a t ed dog s . 
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Table 22. ECG data from normal dogs 
Leada 
I II III 9VF 
R/Q average 3.4 11.2 14.9 16.S 
range o. 5-22. 0 3.0-42.0 2. 5-44.0 4. 5-46. 0 
R/S average 6.0 s.12 8.8 6.8 
range 1.0-20.0 1.5-56.0 l.0-62.0 1.0-27.0 
R/+T average 6.0 9.2 8.5 8.5 
range 1.75-12.0 2.25-40.0 1.5-50.0 1.75-34.0 
R/-T average 7.4 21.0 13.8 16.4 
range 2.5-20.0 1. 25-42. 0 5.25-28.0 10.0-30.0 
ST.!, deviationb 11 22 24 24 
aRatios expressed on basis of R:l and 0 values 
omitted. 
bPercent of total dogs showing devia t ion in lead. 
Notching and slurring are very rare in occurrence in 
the presurgical records with the exception of the T-wave 
which takes on many odd forms. The only other notching 
which occurred was in the R-wave in lead I in one dog and in 
lead III in another. 
P-waves were always upright in leads II, III, and aVF 
with one exception of an isoelectric P-wave in one lead III. 
P-waves are usually upright in lead I, but may occasionally 
be inverted or diphasic. 
Sinus arrhythmia is a normal occurrence; other types of 
arrhythmias were not seen. 
~. :o 
.J.. 
... 
- ·' 
107 
F. Postsurgical ECG Data 
Since no absolute ECG pattern could be found consis-
tently in recordings taken on dogs following production of 
the various pathological conditions, only those values which 
showed a trend to be different from the presurgical controls 
will be discussed. 
Table 23 presents as percentages some of the complexes 
which were thought to possibly have some importance in 
diagnosis of cardiac pathology as compared with normal pre-
surgical percentages. 
Table 23 . Incidence of ECG values expressed in percent 
during presurgical and postsurgical periods 
Treatment QI Qr-T SIII SIII+T -Tr 
Pre surgery 49 95 88 89 60 
Infarct a 75 14 100 71 11 
Shams a 44 75 55 100 56 
Infarctb 68 54 95 81 32 
Shamsb 13 100 75 100 12 
Epicarditis 33 38 75 94 17 
Shams 62 75 92 100 54 
Valvular 
Insuff. 62 63 77 95 58 
Shams 94 88 83 $0 gg 
a Two to twelve days postsurgery. 
brwo to seven weeks postsurgery. 
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Q-waves occur in approximately 50 percent of the cases 
in each lead and any two l eads having a Q-wave from the same 
dog at any one time is a very random type phenomenon. Al-
though Srr and SaVF occurred at the same time in 90 percent 
of the presurgical records, the same pattern was found post-
surgically. SIII occurred in the greatest percentage of 
records in each of the six groups, and it is followed by an 
upright T in 90 percent or more of the records except in the 
infarcted and valvular insufficiency dogs. It is thought 
that the failure of the S in lead III to be followed by an 
upright T is an important indication of myocardial damage. 
In addition to the dogs with infarction and epicarditis, three 
records i n which it appeared in the valvular insufficiency 
shams came from onn dog in which the left ventricle had been 
punctured rathtr then using the atrial approach, and conse-
quently had a small amount of myocardial damage. Another 
factor which appears to be important is the presence of a 
Q-wave in lead I being followed by an upright or absent T-
wave. In all cases the incidence of this phenomenon was 
higher in dogs with lesions. This is especially true in the 
recently infarcted dogs and in the epicarditis dogs. Twenty-
four of JO recordings taken on 14 dogs, 2 to 12 days, fol-
lowing infarction showed: a) 16 with Q-waves with absent 
or upright T-waves in lead I, b) 6 with S-waves with inverted 
T-waves in lead III, and c) 2 showing both a and b. In 
. ' 
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addition, 3 showed a Q-S complex in lead I and one showed it 
in lead III. Six showed ectopic beats at 2 to 3 days fol-
lowing surgery and 4 showed inverted P-waves in one or more 
leads. 
In the six remaining records four had inverted P-waves 
in lead I and three of these had ST deviation in 2 or more 
leads. However, two looked normal. Figures 39 through 48 
(Appendix B) show the appearance of the various complexes 
discussed. 
It was thought that the decreased percentage of negative 
T-waves in lead I might be of some importance. However, its 
occurrence in only about 50 percent of normal records and 
infarct shams having a decreased percentage prevent this ob-
servation from being of any consequence. ST deviation did 
not turn out to be as good an index of cardiac pathology as 
had been anticipated from preliminary studies. ST deviation 
did occur following the production of pathology, however, a 
large percentage of normal ECG's showed ST deviation also. 
But, as was pointed out earlier, the deviation in presurgi -
cal nonnals were quite small. This same pattern was seen in 
sham-operated dogs (See Table 24) where a good share of the 
dogs showed ST deviation in 2 or more leads. Here again the 
values were usually 1 mm. or less . ST deviation did occur 
more often in dogs with pat hology than in shams except the 
early infarction dogs . This in itself cannot be considered 
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to be especially important in the light of the normals. Here 
is one phase where absolute measurements are probably war-
rented for in the infarcted dogs 64 percent of the records in 
which deviation occurred were 2 mm. or more in the early 
stages and 82 percent in the later stages. The R/ST ratios 
did not show this difference as well as expected. Deviation 
up or down seemed to be a random occurrence. 
R/Q ratios varied considerably. Q-waves were not present 
in many cases and when they were present they were often so 
small that measuring and calculation of ratios were subject 
to a large error. No particular pattern was noticed. In-
dividual dog data on a serial basis are presented in Tables 
33 through 38 (Appendix A) with respect to certain complexes 
and values (R/S, R/T, Qr, Srrr, T-waves, QT and PR). 
An observation which was noted, but which is not evi-
dent from Table 24, was that the R/S and R/T ratios decreased 
in the recordings following production of lesions. Actually, 
the R did not decrease in size so much, in fact it may have 
even increased, but both S and T amplitudes were increased. 
The reason the table does not show this well is that some 
large ratios increased the over-all average. The figures 
for negative T are not very reliable because only a very few 
r ecords showed negative Trr (12.5 percent and 59 percent of 
these were in infarcted dogs). Since negative T occurs i n 
lead II in a relatively high percentage of the records after 
' ' 
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infarction it might be considered as having some importance. 
However, if one examines individual serial records {Table 33, 
Appendix A) one sees the pattern is very random. 
Time durations of the various complexes varied so much 
that they are relatively unimportant as diagnostic aids for 
the three conditions present. 
Notching of R did not occur as often as had been antic-
ipated. Only 25 percent of infarction records from 2 to 12 
days showed notching and less than 10 percent of the records 
after 12 days. The incidence of notching in recordings from 
the other groups was less than 3 percent. 
Other than infarction dogs, ectopic beats were seen in 
only two recordings of a valvular insufficiency subject (dog 
41). 
In swnmary it may be said it is quite understandable as 
to why canine elect rocardiography remains an empiric science. 
With the tremendous variations in the normal recording it is 
difficult to set up definite standar ds and deviations from 
these standards which can be considered definitely abnormal. 
From the above data the following points indicate pathology: 
1. Presence of ventricular extrasystole (ectopic 
beats). 
2. Presence and persistence of inverted P-waves. 
3. ST deviation of 2.0 mm. or more. 
4. Q-waves in lead I followed by positive T-waves. 
Table 24. Comparison of complexes of dogs with lesions to shams 
Lead !ta 
I IS I IS E ES VI VIS 
2 - 12 days 2 - 7 weeks 
R/S mean 6.0 7.6 6.1 6.8 12.6 17.5 13.8 15.2 
range 0.3-2$.0 l~0-21.0 1.25-22.0 1.0-16.0 3.0-29.0 1.5-44.0 l.~5-66.0 1.75-64.0 
R/+T mean 6.7 3.5 8.0 9.2 6,2 10.8 7.6 10.6 
range 1.0-20.0 1.45-6.0 1.0-32.0 2.5-16.5 J.0-25.0 3.25-36.01.25-24.0 2.0-21.25 
R/-T mean 7.1 17.0 20.9 0 7.5 20.0 32.0 3.75 
range l.0-28.0 6.75-39.0 3.0-4.5 
ST+ %b 33 45 73 28 62 31 42 14 
%-recordc 50 75 55 33 62 56 66 25 
PR mean .114 .118 .108 .115 .123 .108 .121 .12'5 
range .08-.14 .10-.14 .os-.16 .10-.12 .10-.16 .10-.16 .08-.18 .08-.14 
QT mean • 221 • 229 • 212 • 234 • 208 • 228 • 215 • 208 
range .16-.28 .20-.26 .16-.26 .20-.26 .16-.26 .20-.28 .18-.24 .16·.24 
aAmplitudes expressed as ratio of R to complex durations expressed in seconds. 
bpercent of dogs showing deviation. 
cPercent of records having deviation of dogs with deviation. 
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5. S-waves in lead III followed by inverted T-waves. 
6. Decreased R/S and/or R/T ratios. 
No correlation could be found between ECG recordings and 
the severity of cardiac lesions found upon necropsy or with 
the rise in serum enzymes. There are apµirently no consis-
tent changes in the ECG with respect to a.mount of pathology 
i.e., a small les ion will cause as much change as a large 
lesion if a change occurs. 
G. Necropsy Findings 
1. Infarction dogs 
Fourteen dogs in which infarction was produced were 
sacrificed at various intervals from 10 days to 20 weeks 
following production of pathology. Three others were ne-
cropsied immediately after death. One of these dogs died of 
massive myocardial infarction 10 hours after surgery. The 
other two died from hemorrhage when the coronary artery was 
punctured or burst. 
The 14 dogs sacrificed showed various a.mounts of in-
farcted tissue in the left ventricle ranging from less than 
1 cm. in diameter and involving only the endocardium to those 
involving nearly one -half the left ventricular musculature 
and varying in depth from involving only the endocard.ial 
portion of the myocardium to being transmural in nature . 
(See Figures 14 through 20 , Appendix B.} 
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Generally speaking most dogs had a very slight amount 
of adhesions of the lung to the pleural wall and to the peri-
cardia! sac in the area of surgery. There were adhesions of 
the sac to the epicardium in every case. It seemed that the 
larger the infarcted area was the more adhesions of the sac 
to the epicardial surface occ·urred. Usually little other 
gross pathology was noted. Those cases in which other ab-
normalities occurred will be found in the individual dog ne-
cropsy synopsis in the appendix (Appendix C). 
Sham-operated dogs showed very little evidence of any 
abnormalities. There was generally a small amount of ad-
hesions of lungs to pleural wall and/or pericardial sac in 
the surgical area. Adhesions of the sac to the epicardium 
were minimal and often completely absent. The kidneys of dog 
14 were very jaundiced in appearance but were of normal size 
and no signs of pathology could be seen. Dog 32 showed two 
small infarcted areas in the left kidney, one old depressed 
scar tissue area and one raised and red. The liver of dog 
33 seemed to be enlarged and quite congested; however, no 
other signs of pathology were noticed. A small circumscribed 
tumor was found in the area of the bifurcation of the 
uterine horns in dog 40. 
Other dogs appeared to be completely normal. It is be-
lieved that pathology found in the four dogs discussed above 
did not contribute large enough amounts of enzymes to the 
I I 
~ 
I 
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serum to be of any great significance. The adhesions which 
occurred could possibly affect the ECG because of the effect 
of position. The exact effect, if any, :ould be very dif-
ficult to access. 
' Figures 12 and 13 (Appendix B) show examples of hearts 
of sham-operated dogs. 
2. Epicardit is dogs 
Si x dogs were necropsied in which an epicarditis and 
pericarditis were produced. (See Figures 21, 22, and 23, 
Appendix B). The amount of pathology did not vary much among 
individuals. In most cases about three -fourths of the sur-
face of t he heart was involved. In one case the entire 
pericardial sac was adhered t o the epicardium and was very 
difficult to remove (Figure 21) . This dog died f rom path -
ology produced. The surface of t he heart was generally 
granulated in appearance with some areas of small hemorrhage 
and hyperemia. A purulent exudate was never seen. There was 
no odor from any of the specimens. However , one had a small 
amount of dark viscous fluid in the pericardial sac . This 
dog had been dead several hours before it was necropsied and 
there was a slight odor which was attributed t o post~nortem 
changes. 
As in the infarction dogs there were a few adhesions of 
lungs to the pleural wall in the ar ea of the incision and 
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also to the pericardial sac. In all cases the amount of ad-
hesions of the sac to the epicardiu.m was extensive. 
Three of the six specimens were cultured aerobically 
and anaerobically on blood agar. No growth was seen. It was 
thought that all cases were sterile. 
The three sham-operated epicarditis dogs were very near 
to normal . There were no adhesions of the pericardial sac 
to the epicardium. There was no indication of any type of 
lesion in any of the hearts. Dog 1$ had a fairly severe 
pleuritis on the right side. This was cultured and found to 
be negative for bacterial growth. This same dog had a 
slight right A-V valvular proliferative endocarditis. In 
dog 35 there was a slight amount of irritation (about 5 mm. 
in diameter) on the left ventricle apparently ~ram the sili-
cone rubber tube. 
All other organs and tissues appeared to be nornal. 
3. Valvular insufficiency dogs 
Eleven do gs were operated on to produce a valvular in-
sufficiency. Four of these were done using the Markowitz 
(9$) technique. Two died of cardiac rupture and one died from 
too great of insufficiency. Seven were done by the method 
described previously. The first two of these died during 
surgery, one from ventricular fibrillation and one from 
rupture of the anterior vena cava. The other five sur-
vived surgery and upon necropsy showed various degrees of 
insufficiency. Dog 41 had a left A-V insufficiency which 
was quite severe. There was al so a negatative endocarditis 
. 
' 
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fo und on the right A-V valves, apparently a result of the 
left A-V insuffici ency. The liver was swollen and appeared 
to be mildly cirrhotic . Dog 42 had the greatest amount of 
insufficiency of the 5 dogs in this group. This dog showed 
necrosis and cirrhosis of the liver grossly, plus a passive 
congestion throughout. The other three dogs had milder A-V 
insufficiencies, and showed nothing spectacular other than 
some right ventricular dilation. See Appendix C for more 
details. (See Figures 24 through 27 and 36 through 38, 
Appendix B. ) 
Five dogs were sham-operated, one by the Markowitz 
Met hod (No. 3) and four by open heart surgery. Dog 3 showed 
a small area of scar tissue in the left ventricle where it 
had been punctured. The other four hearts appeared to be 
normal except J~r the area of silk in the atria where the 
incision was made. There was a slight amount of adhesion 
of lungs to the pleural wall and pericardial sac. There were 
also adhesions of the sac to the heart in the region of the 
sutures . These adhesions were easily broken down. There 
were no other gross indications of pathology. 
H. Histopathological Findings 
1. Infa r ction dogs 
The type of histopathology found in the infarcted area 
of the ventricle of each dog was very similar in appearance. 
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(See Figures 27 through 30, Appendix B.) These lesions were 
characterized by predominant replacement fibrosis with scar 
tissue formation, myocardial necrosis and infiltration of mono-
cytes and some calcification of the necrotic myocardium. In 
some cases it appeared the area was enlarging as the cells 
adjacent to the fibrotic area showed swollen granular myo-
cardial fibers with light, round, swollen or pyknotic nuclei. 
Congestion and hemorrhage were often seen in and adjacent to 
necrotic areas. In addition, adjacent areas of myocardium 
which were pale and grey, yet not frankly necrotic, showed 
considerable cloudy swelling with granular cytoplasm micro-
scopically. Nuclear changes were not prominant in these 
cells. 
Sections taken from the myocardium of sham-operated ani-
mals appeared to be normal. 
In those dogs sacrificed earliest following myocardial 
infarction there was some cloudy swelling of the liver with 
some fatty infiltration. There was no evidence of actual 
necrosis, however. In a few cases there were small foci of 
swelling and some cells appeared granular, otherwise livers 
appeared normal. In the dogs sacrif iced l ater the livers 
appeared to be normal. 
Other organs, which were sectioned and studied micro-
scopically, generally appeared normal. In one case an 
infarct was seen in a kidney. This was very small and the 
1; 
,, 
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rest of the section was normal. Sham-operated dogs were 
normal throughout. 
The tumor found in dog 40 was a fibroma. 
2. Epicarditis dogs 
Pathology was confined almost entirely to the epicardial 
surface of the heart. In only one case was there any indi-
cation of the myocardium being involved. This dog showed 
some necrotic changes, pyknotic nuclei and some hyaline de-
generation of the muscle fibers. In the other dogs the myo-
cardium appeared to be entirely normal except for a hyperemia 
of the outer layers of muscle. The main changes seen were 
confined to a fibrosis with many spindle shaped nuclei of the 
connective tissue cells appearing. Polynuclear cells were 
minimal as was the appearance of other circulatory cells, In 
some areas there was hemorrhage on the epicardial surface. 
A few giant cells were noted throughout the area involved. 
There was also an increase in capillaries throughout the in-
volved area. Figures 31 through 34 (Appendix B) are examples 
of histopathologic findings. 
Studies of other organs and of the sham-operated dogs 
indicated no significant changes. 
3. Valvular insufficiency dogs 
Grossly cardiac dilatation in dogs was based upon the 
finding of enlarged cavernous ventricular chambers, thin 
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ventricular walls, and flattened papillary muscles. Micro-
scopic changes were also present. These changes were thin and 
sometimes wrinkled or cut.led myocardial fibers. 
In most cases thickening of the cusps of the A-V valve 
involved occurred. In dog 41, where left A-V valve was im-
paired, the opposite A·V valve also showed this pathology. 
The edge of the cusps consisted of proliferative fibroblasts 
and collagen fibers. Figure 35, Appendix B, shows an example 
of the valvular change. 
No other changes were noted in the cardiac muscles. At 
the sight of entry in the atrium there was a thin line of 
scar tissue and some monocyte infiltration. However, cellular 
changes were minimal and there was a noticable lack of 
eosinophils which had been expected to appear in thi8 area 
because of the increase in the peripheral circulat ion. 
In dogs 41 and 42 there was distinct evidence of early 
cardiac cirrhosis of the liver. Central veins were very 
enlarged and cells surrounding these veins were in various 
stages of degeneration (Figures 37 and 38, Appendix B). 
Other tissues showed excess interstitial fluids and most 
organs showed cells with cloudy swelling. Both dogs were 
suffering from a passive congestion. The other three dogs 
in this group showed no significant changes upon histolog -
ical examination of any organs other than the heart. 
Histological examination of the five sham-operated dogs 
revealed only an area of fibrosis in the left ventricular 
\ ~ 
I 
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musculature of dog 3, and a thin line of scar formation in 
the atrium of the other four dogs. All other organs appeared 
to be normal. 
I. Symptoms 
Dogs in which myocardial infarction was produced showed 
symptoms of severe depression for three to seven days fol-
lowing surgery. Heart rate was usually increased as was 
respiration. In the first few days there were indications of 
pain . The dogs then showed rapid improvement and appeared 
to be normal in two to four weeks. It must be pointed out 
that dogs were maintained under cage rest and were not per -
mitted to exercise or were not bothered for any reason other 
than routine care, taking blood samples , and ECG recordings . 
Epicarditis dogs showed severe depression for approxi -
mately one week following surgery. Upon auscultation of the 
heart, fluids could be heard for a few days. This sound 
disappear ed and no abnormalties could be auscultated on most 
dogs . One dog did seem to have a sound which sounded gritty 
for one day on the fourth day following surgery. The dogs 
generally showed improvement and appeared normal fo r several 
weeks. This was followed by a mild depression which became 
very severe in do g 37. This dog died three months after pro-
duction of the epicarditis . Several dogs had a frem itus or 
thrill upon palpation of the femoral arteries and a decreased 
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pulse. This continued throughout the remainder of the 
experimental period once it had appeared. Dog 5 showed no 
symptoms after the first week and got along very nicely. 
In all cases appetite seemed to be normal. 
Dogs with valvular insufficiency generally showed in-
creased respiration and heart rate. They were more depressed 
than the epicarditis dogs but not as much as the infarction 
dogs early in the experiment. Dogs 41 and 42 suffered from 
periods of anorexia. They both developed a cough and some 
dyspnea. In addition dog 41 definitely suffered from an 
anasarca. This dog was treated with a diuretic and had a 
peritoneal puncture several times to remove the ascites 
fluid. 
All dogs indicated a valvular insufficiency upon 
auscultation by various degrees of systolic murmur. The 
pulse of dog 41 was barely palpable. Other dogs had periods 
of intermittent fremitus in the femoral artery, but pulses 
remained fairly strong except dog 42 which had a fairly 
strong pulse at first but which gradually became weaker and 
was impalpable shortly before death. 
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V. SUMMARY 
Various types of cardiac pathology (myocardial, in-
farction, epicarditis, and A-V valvular insufficiency ) were 
produced. in 50 dogs by surgical methods. These dogs were 
classified prior to surgery as normal based on physical ex-
amination, hematological studies , and electrocardiograms. 
The upper ranges for normal serum enzyme levels were 
40 units for glutamic oxalacetic transaminase (SGOT), 35 
units for glutamic pyruvic transaminase (SGPT), and 500 units 
for lactic dehydrogenase (SLDH). The clinical Sigma method, 
which has been used in research also, for the assay of SGOT, 
was compared with an establisbed research method of Hergt 
and Langin. It compared very favorably with the latter 
method and in some respects was more advantageous. 
It was found that repeated freezing and thawing of 
serum significantly reduced the amount of enzyme activity. 
It was further found that age is not a factor in 
normal serum enzyme levels. 
Based upon serial enzyme studies following the produc-
tion of myocardial infarctions it was found that SGOT was 
the most reliable, of the three enzymes studied, as a diag-
nostic aid. In addition the relative amount of infarction 
could be fairly well ascertained by the rise in SGOT activity . 
It was found that SGOT began to elevate 8 to 15 hours 
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following infarction, reached peak levels (up to 15 times 
normal values} from 18 to 24 hours and returned to normal 
ranges within 40 to 90 hours. Also, SGPT may rise consider-
ably, up to 10 times normal values, following the more 
severe infarctions. Its pattern was similar to SGOT although 
SGPT never reached the elevations of SGOT following infarc-
tion. SLDH was much more erratic, both for normal serum 
levels and for those following infarction. This enzyme 
reached peak values at 25 to JO hours post-infarction and did 
not return to normal until 80 to 100 hours in most cases. 
However, because of its wide range of normal activity among 
dogs and because of its radical behavior following infarction, 
it cannot be recommended as a diagnostic aid for myocardial 
infarction in dogs at this time. Both SGOT and SGPT should 
be assayed because of the high levels of SGPT and SGOT seen 
in liver necrosis as reported by other workers. 
Serum enzyme assays are of little aid in diagnosing 
epicarditis or valvular insufficiency in dogs; however, they 
may be an important negative finding when coupled with symp-
toms and ECG findings. 
Routine hematologica l studies are of little aid in diag-
nosing any of the conditions presented. 
Electrocardiograms from normal dogs were studied and it 
was revealed l} when a Q-wave occurred in lead I, it was 
followed by an inverted T-wave 95 percent of the cases; 
i 
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2) when an S-wave occurred in lead III, it was followed by 
an upright T-wave in 89 percent of the records; 3) although 
an ST deviation occurred in one or more leads fairly frequent-
ly (20 percent of all recordings in one or more leads I, II, 
III, and aVF), it was never more than 2.0 mm. and in 95 per-
cent was not over 1.5 mm.; 4) inverted P-waves in lead II, 
III and aVF and ventricular extrasystoles (ectopic beats) in 
any lead never occurred; and 5) that there is considerable 
variability from dog to dog and from day to day in voltages 
and time intervals of the ECG. 
Following the production of certain pathological con-
ditions of the heart it was found that certain changes in 
the ECG may be indicative of pathology. These chang~s in-
cluded: the presence of ventricular extarsystoles; the 
presence and persistence of inverted P-waves in leads II, 
III, or aVF; the presence of ST deviation~ 2.0 mm. or more 
in one or more leads; the presence of Q-waves in lead I 
followed by an upright T-wave; the presence of S-waves in 
lead III followed by inverted T-waves; and the presence of 
decreased R/S and/or R/T r at ios. No correlat ion could be 
made with changes in the ECG following surgery with the amount 
of pathology or with the rise of serum enzymes . 
This research has presented many questions which need to 
be investigat ed. It has been only a beginning into a vast 
area of study in the realm of enzymatic chemistry in 
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veterinary medicine. Investigations should continue on all 
species of domestic animals as there are known species 
variabilities and there is always much danger in extrapolating 
results from one species to another. In addition, because of 
the many tissues containing relatively high concentrations of 
the various enzymes, it is imperative that all pathological 
processes which may contribute to the serum activity be in-
vestigated so there is less chance of error in diagnosis. 
Finally, more basic biochemistry and physiology involved in 
these processes must be studied further to understand the 
significance of observed changes. 
1. 
2. 
3. 
4. 
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VIII. APPENDIX A: TABLES 
Table 25. Serial SGOT levels of dogs with myocardial in-
farction (Sigma method) 
Pre-
Hours post surgery Lesion .Dog. surg -
size no. ery 17-22 23-27 28-34 35-43 44-50 54-72 
< 1 cm. 15 18 48 45 39 35 31 31 
11 22 75 64 41 35 33 30 
38 20 68 64 45 36 30 35 
46 22 63 63 57 51 42 32 
1-2 cm. 21 18 170 140 130 118 75 50 
25 37 160 97 105 50 30 29 
51 28 121 88 82 67 48 39 
> 2 cm. 7 14 400 118 95 46 53 30 
24 18 140 193 72 45 49 25 
31 23 80 130 105 62 58 40 
34 27 320 260 110 66 76 47 
45 21 370 410 280 150 130 65 
49 32 400 305 235 70 47 33 
50 27 230 240 81 50 40 30 
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Table 26 . Serial SGPT levels of dogs with myocardial 
infarction 
Pre-
Lesion Dog surg- Hours post surgery 
size no. ery 17-22 23-27 28-34 35-43 44-50 51-72 73-90 
< 1 cm. 15 25 
11 17 
38 20 
46 36 
1-2 cm. 21 20 
25 28 
51 30 
> 2 cm. 7 19 
24 20 
31 17 
34 24 
45 18 
49 24 
50 21 
24 
48 
46 
36 
25 
44 
34 
29 
46 
48 
34 
27 
42 
32 
20 
42 
40 
35 
28 
39 
33 
23 
41 
38 
34 
29 
37 
38 
31 
46 
32 
36 
31 
25 
36 
24 
32 
31 
33 
25 
24 
35 
240 125 101 87 76 77 
88 93 89 80 55 62 
60 55 65 83 61 56 
100 100 92 86 64 53 
160 220 220 171 139 100 
150 140 130 160 125 78 
83 99 76 69 62 50 
Table 27. Serial SLDH levels of dogs with myocardial 
infarction 
Pre- Post surgerJ'.: 
Dog surg- Hours r>ais 
no. ery 18-30 31-48 49-70 4-8 9-13 14.-18 
46 130 385 495 535 180 - -
25 165 1225 1075 1150 360 - 175 
51 100 580 265 240 - 550 
31 170 280 230 - 100 
34 450 800 650 500 110 .. -
45 140 1125 375 370 350 - 190 
49 350 820 5.00 225 190 210 
50 365 375 290 180 225 
20 
30 
28 
40 
28 
22 
20 
56 
29 
38 
44 
49 
64 
47 
< 19 
140 
280 
I 
I., 
1m 
l... 
I 
l11; 
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Table 2$. Serial enzyme levels of dogs sham-operated for 
myocardial infarction (Sigma} 
re-
Dog surg- Hours Eost surgeri 
no. ery lZ-22 2J-2Z ~8-3~ 3~-~3 9:!:-20 21-z2 z2-20 
SGOT 
1 23 25 23 23 25 23 21 16 
13 25 35 32 24 32 33 27 30 
14 24 36 26 25 22 17 24 20 
22 20 23 16 16 18 20 20 i6 
32 20 41 41 39 29 25 27 25 
33 18 37 40 25 25 19 18 20 
39 27 27 20 25 19 24 28 24 
40 21 37 43 25 25 30 33 32 
SGPT 
1 12 15 14 12 15 15 19 18 
13 23 38 39 38 36 35 32 38 
14 18 20 19 17 15 16 20 17 
22 20 24 18 17 17 16 20 18 
32 15 32 29 29 34 20 20 20 
33 18 22 30 26 24 24 24 24 
39 26 26 21 20 29 1$ 28 25 
40 24 25 24 25 24 28 25 22 
SLDH 
33 240 130 110 70 120 
39 325 $5 165 - - - 150 
40 205 2$0 190 175 - 160 
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Table 29. Serial enzyme levels of epicarditis dogs (Sigma ) 
Pre- Post surge a 
Dog surg- Da!s Weeks 
no. erv 2 5 8 12 3 4 5 6 
.fil!Q1 
5 17 20 21 24 13 22 18 29 
10 27 16 22 17 14 23 25 22 22 
26 29 25 37 31 25 23 22 21 
36 14 22 32 20 27 28 29 30 
37 28 28 JO 23 27 19 26 27 
43 33 25 32 30 - 23 21 
SGPT 
5 18 27 20 23 27 18 24 27 
10 17 13 21 12 14 15 25 19 15 
26 22 21 36 37 25 25 16 20 22 
36 13 19 30 19 17 22 25 23 
37 23 28 25 24 - 21 26 23 21 
43 20 26 - 23 19 15 
SLDH 
26 400 100 - 110 190 
36 120 205 - 290 - 260 
37 70 205 265 
43 200 - 200 - 300 470 - 555 
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Table 30. Serial serum enzyme levels of sham-operated 
epicarditis dogs (Sigma) 
Post surgery 
Dog Pre- Da~5 Weeks 
no. surgery 2 5 8 12 3 4 5 6 
fil1QI 
18 18 l.4 lS 17 24 20 28 27 27 
29 19 29 26 25 15 16 16 15 15 
35 21 17 17 19 23 31 33 35 34 
.§QfI 
lS 16 17 14 18 20 18 21 25 25 
29 23 22 16 19 15 15 21 15 16 
35 20 20 20 18 17 24 22 21 20 
SLDH 
29 150 130 175 140 150 
35 75 75 - 225 90 120 
150 
Table 31. Serial enzyme levels of valvular insufficiency 
dogs (Sigma) 
Da!s 
ost surgerr 
WeeICs Dog Pre-
no. surgery; 4 6 9 12 3 5 g 12 
SGOT 
20 18 24 24 23 27 22 32 24 25 
27 20 17 15 16 19 25 20 15 19 
ml 30 34 26 18 26 18 22 19 18 28 
41 29 34 29 - 39 36 31 29 71 
42 24 30 23 25 24 19 39 35 
SGPT 
20 16 27 33 25 26 30 23 18 20 
27 23 15 13 14 15 16 14 17 18 
30 31 20 20 20 20 19 22 21 24 
41 24 38 24 - 35 32 29 24 140 
42 15 24 22 21 16 36 40 32 
SLDH 
27 45 - 175 - - 380 - 250 180 
30 200 - - - 380 - 325 250 200 
41 455 475 .280 - 480 - 355 230 250 
42 225 - 290 - 225 375 300 170 
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I ' Table 32. Serial enzyme levels of sham-operated valvular . 
insufficiency dogs (Sigma) 
Post s11rgery 
I Dog Pre- Da:y:s Weeks 
, _ !1. no. surgery; 4 6 9 12 3 4 6 g 
SGOT 
3 26 24 23 15 22 
4 53 56 40 41 51 50 46 46 45 
:-- ~ 
19 20 25 20 14 22 
47 28 35 27 30 30 30 26 26 33 
48 29 27 24 25 28 29 26 24 29 
SGPT 
3 20 22 21 15 21 
4 32 49 30 29 31 JO 28 24 29 
19 17 23 21 20 18 
'· 
47 26 25 25 28 26 30 29 25 25 
48 17 19 21 25 28 30 28 24 29 
SLDH 
47 160 - 255 240 230 225 
48 210 230 - 230 225 230 
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Table 33. ECG data from myocardial infarction dogs -
arranged by age and as to severity of lesion 
found at necropsy 
Po git surgeri 
Da~~ \·l~~k~ 
Age PS I PS II 2-2 6-12 2-!:t 2-z 2-1z 
RLS ratios 
l 5.5 5.5 7.25 8.0 
1 3.0 2.5 3 3.5 3.0 2.0 
l 9.5 8.0 lg.25 7.0 10.5 9.75 
~b 5.0 56.oa 2 .o 25.0 6.75 8.0 15.0 50.oa 18.0 21/0 
2 10.0 20.0 20.0 2.25 
2 2.5 3.5 3.0 16J O 3.5 
2 14.0 17.0 10.0 - 22.0 
2 11.5 24.0 8.0 16/0 12.0 
2 4.0 6.0 1.5 5.75 
2 2.0 0.3 o. 5 1.75 1.25 2.5 
! 3 3.0 2.5 2.75 1.75 2.0 3.0 3 20.0 19/0 5.0 3 1.5 2.0 1.0 1.25 1.0 2.75 
RLT ratios 
l 11.0 10.0 ,). 0 8.0 
1 6.0 3.75 :3. 0 3.5 2.5 1.0 
1 -9. 5 1.25 11.25-28.0 32.0 -39.0 
2b 6.75 i~.o 7.0 17.0 -6.75 6.0 
2 -30.oa -1 .o -6.0 21.0 
2 6.2~ -6.0 20.0 2.25 
2 -40.0 8.5 3.0 -4.0 -17.0 
2 5.5 5.5 4.0 - 7.25 
2 6.5 8.0 3.0 4.0 12.5 
2 13.25 12.5 -1.0 3.25 
2 4.75 -2.0 1.0 3.5 2.0 6.0 
3 7.5 3.25 8.5 5.5 3.5 5.5 
3 10.0 9.5 7.5 
3 2.75 4.0 -1.5 1.5 1.0 -4. 25 
a< 1 mm. 
bsecond infarction. 
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Table 33. (Continued ) 
Days 
Post surger W 
eeks 
Age PS I PSII 2 - 5 6-12 2 -4 5-7 9 -17 
P-R interval ( sec. l 
1 ·. 08 . 08 . 10 .08 
1 .10 .14 . 10 . 12 .10 .10 
1 . 12 . 12 . 12 .10 . 12 . 10 
2b .12 .12 . 14 .12 .16 .14 
2 . 12 .10 . 10 .10 
2 .12 . 12 .14 .12 
2 . 12 . 08 . 08 . 12 . 10 
2 .10 .10 .10 . 08 
2 .10 . 12 . 14 .12 . 12 
2 . 08 . 10 .12 . 10 
2 . 10 . 10 .10 . 08 .10 .08 
3 . 12 . 1 2 . l~ .12 .12 .12 .12 
3 .10 .10 . 10 
3 .10 . 14 . 14 . 14 . 12 .10 
Q.-T interval { sec 1 l 
1 . 24 • 24 • 22 . 20 
1 .22 . 22 • 24 • 24 . 22 • 24 
1 . 20 . 20 . 20 . 20 .22 .18 
2b • 24 . 26 • 24 . 24 . 26 . 26 
2 . 20 .18 .16 . 22 
2 • 24 • 20 • 24 • 24 
2 . 22 • 22 .20 . 20 . 18 
2 . 20 . 18 . 20 . 20 
2 . 24 . 22 . 22 . 22 . 20 
2 . 20 . 20 . 20 .16 
2 . 20 . 24 • 22 • 20 . 20 . 22 
3 . 26 . 26 . 28 • 24 . 20 . 26 
3 • 24 • 24 • 24 
3 . 22 .20 • 24 . 20 .20 . 22 
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Table 33. (Continued) 
r>ais 
Post surgerv 
Weeks 
Age PS I PS II 2-2 t>-I2 2-~ ~-z 2-Iz Q, -T g, -T Q, -T Q, -T Ql -T g, -T Q -T 
1 - + + + + -
1 + + + + + - - + 
1 - - - - - + 
2b - + - + + + - + + 
2 - + + + + + + 
2 - + + + 
2 - + + + - + + + + 
2 - - - + + 
2 - + - + - + - + + 
2 - + - + - + + 
2 + + - + - + - + - + 
3 + + + - + 
3 + - + - + 
3 + + + + + + + - + + 
S3 +T S3 +T S3 +T S3 +T S3 +T S3 +T S3 +T 
1 + + + + + + + + 
1 + + + + + + + + + + + + 
1 + - + + + - + - - + 
2 + + + + + + + + + - + + 
zb + - + - + - + + 
2 + + + + + + + + 
2 + - + + + - + + + 
2 + + + + + - + + 
2 + + + + + + + + + + 
2 + + + + + - + + 
2 + + + - + + + + + + + + 
3 + + + + + + + - + + + + 
3 + + + - + 
3 + + + + + - + + + 
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. on 't'tP •:t] I ..L. I 6i l# •l Table 34 • ECG data from sham-operated myocardial infarction 
dogs 
O§t ~~i:gerw 
-. :\ ·,.~•q;r1r • Days eeks 
Age PS I PS II 2-2 6-14 J-:Z l~-16 
- ............... . - R/S ratios 
l. - . . -
1 1.5 1.75 2.75 
1 4.25 5 6.75 - 7.0 
2 10.5 4.25 - 5.0 
2 1.5 1.5 - 2.0 1.0 
2 7.25 9.0 - 21.0 5.5 
2 13 . 0 12. 0 8. 5 lJ. O - 16.0 
2 2. 25 2.5 4.5 4 . 5 2.5 2 . 25 
3 12. 5 13.5 25/0 - 12.5 8.0 
BLT ratios 
1 J.O 2.75 1.5 
1 -17.0 4.5 3.25 - 8. 75 
2 8. 0 5.25 - 6.0 
2 3. 5 2.7~ - 4.0 2.'65 
2 11.0 -44 . 0 - 4.25 11. 
2 2 . 25 5. 0 -17.0 2. 25 - 8. 0 
2 4.75 ~-() 4.6 1.75 2.5 2. 5 
3 50.oa .o 4. - 16.5 4 . 0 
PR interval 
1 .10 . 08 .12 
1 .14 .12 .12 - .12 
2 .12 .12 - .12 
2 . 08 . 12 - . 10 . 12 
2 . 08 . 08 . 12 .10 
2 .12 .12 .10 - - .12 
2 . 12 . 12 .10 . 14 . 12 .12 
3 .12 . 12 . 14 - . 10 . 12 
a T was on o. 5 mm. 
,,j 
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Table 34. (Continued) 
ost surgerx 
Daj;§ Weeks 
Age PS I PS II 2-5 6-14 3-7 14-16 
.Q.T interval 
1 .20 .20 • 24 
1 • 24 .22 .24 - .24 
2 .22 .20 - .22 
2 .24 .24 - • 24 • 24 
2 .24 • 24 - .26 .26 
2 .20 .24 .20 
2 .24 • 26 .22 .20 .20 .24 
3 .24 • 24 .24 - .20 .26 
Qr ·T Qr -T Qr -T Qr -T Qr -T Qr -T 
l + + - -
l + + 
2 + + + - + + 
2 
2 - + + 
2 - + - + + 
2 + + + + + + + - + + 
3 - + - + - + + 
srrr+T srrr+T srrr +T srrr+T Qrrr+T Qrrr+T 
l + + + + + + + + + + + + 
l + + + + + + + + 
2 - - + + 
2 + + + + + + + + 
2 + + + - + + + + 
2 
2 + + + + + + + + + + + + 
3 + + + + - - + + 
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Table 35. ECG data from epicarditis dogs 
Weeks 
Age PS I PS II -i~r---?t-b z-12 12-lZ lB-2!1: 
R/S ratios 
1 23.0 7.25 - 15.0 12.5 11.0 
1 12.0 7.5 8.0 6.5 4.0 
2 11.0 6.0 12.0 10.0 16.5 13.5 29.0 
2 3.25 5.1 5.5 4.0 4. 5 3.0 3.5 
2 5.5 9.25 10.0 11.25 16.0 9.0 12.5 
3 4.75 - 5.75 - - 23. 0 6.25 
l!LT ratios 
1 5.75 2.0 - 8.0 4.0 7.25 
1 8.0 10.0 2.25 4.25 3.0 
2 16.0 8.0 3.0 4.0 3.75 6.75 10.0 
2 8.0 12.0 4. 5 3.0 7.0 4.0 3.0 
2 14.0 14.0 1.5 7.0 5.0 6.25 25.0 
3 4.75 - 1.75 - - -7.5 17.0 
PR interval 
1 .12 .12 - .14 .14 .12 
1 .10 .10 .12 .10 .12 
2 .06 .08 .10 .12 .12 .14 .10 
2 .10 .10 .16 .14 .16 .12 .14 
2 .10 .10 .12 .12 .12 .10 .10 
3 .12 - .14 - - .10 .12 
.Q.T interval 
1 .22 • 24 - .20 .20 .20 
1 .22 .20 .20 • 20 .26 
2 .24 .18 .20 .18 .20 .20 .20 
2 . 22 .24 • 24 .22 • 24 • 24 .22 
2 .20 .20 .18 .20 .22 . 20 .16 
3 .24 - . 24 - - .18 .22 
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Table 35. (Continued) 
Age PS I PS II 1-J li-b 
Weeks 
z-12 12-lZ 1B-2li 
Qr -T Qr -T Qr -T Qr -T Qr -T Qr -T Qr -T 
1 - - + + + - + + 
1 + + + + 
2 - + + 
2 - + + + - - - - + 
2 - + + - + - - + 
3 - - + + 
srrr+T Qrrr +T srrr +T srrr +T Srrr+T srrr +T srrr +T 
1 + + + + + + + + + + 
1 + + + + + + + + + + 
2 + + + + - - - + + - U~. 
2 + + + + + + + + + + + + + + 
2 + + + + + + + + + + + + + + 
3 + + - + - + + 
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Table 36. ECG data from sham-operated epicarditis dogs 
Week a 
Age PS I PS II l 6-8 10-14 20-22 28 JO 
RLS ratio 
1 7/c 14.0 25.0 20.0 lg76 20 .0 2 21 0 22.0 44 .0a 1.5 42·'cfi 10.5 10. 0 • 
2 J.5 2.75 6.0 4.5 
R/T ratio 
1 7.5 -14.0 3.25 6.75 12.5 10.0 
2 -42.0 11.0 5.5 9.0 36.0 21.0 6.5 -20.oa 
2 -24.0 8 .25 4.0 4.0 
PR interval 
l .08 .08 .10 .10 .10 .10 
2 .10 .12 .14 .16 .12 .16 .12 .10 
2 .10 . 10 .12 .10 
l .20 .20 .24 .22 
QT interval 
• 20 .20 
2 .22 .28 .2s .26 .24 .20 .22 .22 
2 .22 .20 .22 • 24 
QI -T Qr -T Qr -T Qr -T Qr -T Qr -T Qr -T QI -T 
l + + + + + + + + + + + + 
2 + + + + + + + + + + + 
2 + + + + 
SJ;rr+T Srrr+T Siri+T Srrr+TSIII+T srrr+T s rrr+T srrr+T 
1 + + + + + + + + + + + + 
2 + + + + + + + + + + 
2 + + + + + + + 
a< 1 mm • 
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Table 37. ECG data from valvular insufficiency dogs 
Pre- vleeKs 
Age sure;ery 2 4-7 10-12 13-20 22-27 31-32 36-3g 
RLS ratio 
2 3.0 7.5 6.0 6.5 8.5 12.0 1.4.0 15.25 
2 5.75 1.75 3.0 3.0 32.0 3.0 
2 5.0 3.0 1.25 lO.oa 
3 11.5 7.25 5.75 4.5 12.0 
62.oa 35/0 3 29/0 29/0 JO/O 62.oa 
RLT ratio 
2 5.0 8.5 7.5 6. 5 2.5 8.75 4. 5 7.5 
2 4.25 1.75 2.0 1.75 9.0 3.5 
2 6.25 1.25 2.0 lo.oa 
3 23/0 7.25 7.5 4.5 24.0 
3 10.0 8.25 15.0 -32.0 lJ.O 17.5 
PR interval 
2 .10 .12 .12 .12 .16 .1.4 .16 .10 
2 .10 .10 .12 .12 .10 .12 
2 .12 .12 .08 .18 I 3 .08 .10 .12 .10 .10 3 .12 .1.4 .10 .10 .16 .12 
Q.T interval 
2 .24 • 26 .24 .24 .24 .24 .22 .22 
2 .24 .20 .24 .22 .24 .20 
2 .22 .20 .22 .18 
3 .20 .18 .20 .18 .24 
3 .24 .22 .20 .18 .20 .20 
~ 1 mm. 
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Table 37. (Continued) 
Pre- Weeks 
Age surgery z 4-7 10-12 13-20 22-27 31-32 36-38 
.9.r. -T Qr -T Qr -T Qr -T Qr -T Qr -T Qr -T Qr -T 
2 + + + + + + - - + - + - + + 
'.: ,~;Jl I 2 + + + - + - - - + + .~ , ' V 2 - - + + . ·~l .. . 
3 + + + + + + + + .~: -~~ ~.;~ ~~ I - -
3 + + - - - + + + + 
s111+T srrr+Tsrrr+T srrr+T srrr+T srrr+T srrr+T srrr+T 
O" \o."il_ __:f ... ' , -... ... 
i lVl ;i>:l''- j.,, ·-
2 + + + + + + + + + + + + + + + + 
2 + + + + + + + + + + + + 
2 + + + + + + + + 
3 + + + + + + + + + + 
3 
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Table 38. ECG data from sham-operated valvular insufficiency 
dogs 
Pre- DaI:s Weeks 
Age surger~ 2 10-12 !J: 6 10 lJ 
RLS ratio 
1 4.0 6.0 22/0 
2 3.0a 19.0 
30/0 64.0a 2 56.0 37.0 8.5 
2 l)c 9.0 4. 5 6.0 2.75 3 38 0 30/0 20/0 
RLT ratio 
1 - 8.0 -4.5 7.25 
2 - 1.25 -3.0 
2 28.0 15.0 21.25 18.5 17.25 
2 3.0 6.0 3.0 2.5 2.0 
3 -19.0 15.0 9.25 
interval ~sec 1 } PR 
1 .08 .14 .12 
2 .12 .08 
2 .10 .12 .12 .12 .12 
2 .10 .14 .14 .14 .14 
3 .14 .12 .12 
QT interval ~sec 1 } 
1 • 20 .24 .16 
2 .28 .20 
2 .18 .20 .18 .20 .20 
2 .22 .20 .22 .24 .22 
3 .24 .20 • 24 
Qr -T Qr -T Qr -T Qr -T Qr -T Qr -T QI -T 
l + + + + + 
2 + + + + 
2 + + + + + + + + 
2 + + + + + + + + 
3 + + + + + + 
srrr+T srrr+T srrr+T srrr+T srrr+T srrr+T srrr+T 
1 + + + + 
2 + + 
2 + + + + + + + + + + 
2 + + + + + + + + + + 
3 
a< l mm. 
I• 
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Table 39. Hema t ologica l studies of dog s during cours e of exper imentation 
No.Date HT Hb WC RBC Baso Eos Lymph Stab Ses Mono 
14 Pre-
sur- 45.0 16.4 13.04 6. 91 .71 2 0 19.0 3.3 70.6 4.14 
gery (37-53)(12.9-19.4)( 6.25-22.2)(5.22-7.9 )(0-4)(0~7)( 7-28)(0- 7)(61-73)(1-15) 
Infarction 
9 1 wk. 44 .4 16.2 16.18 7.09 .67 2.67 16.67 5.1 72.8 3.1 
(40-50)(13. 9-17.8)( 6.04-25.2)(5.93-7 . 74)(0-1)(1-4)(12-22)(2- 9)(67-76)(1- 5) 
3 2 wk. 41 4.1 15.67 6.l..4 .33 3 25..6 4 63 4 
(37-43)(12.7-15.6)(12. 9-18.52)(5.26 -6.85)(0-1)(1-5)(18-35)(1- 6)( 60-66)(3- 6) 
6 3 wk. 45.5 16.6 14.09 6.9 .75 6.2 14.2 4.2 69.3 4.7 
(42 -49 )(1.4.3-18.8)(7.65-23.5 )(5.74-8.5 }(0-5)(1-20)( 9-18)(1-10)(53-74)(2- 8) 
1 4 wk. 48 
1 15 wk. 46 
16.0 
18.2 
7.35 
7.66 
0 
1 
2 
2 
33 
18 
3 
3 
59 
74 
3 
2 
Infarct Sham 
8 Pre-
s ur- 46.4 17.0 12.28 6.51 .625 2.63 20.0 2.12 70.0 4.1 
gery (43-51 )(16.0-19.1)( 6.72-19.4)(6.69-8.68)(0-1)(1-9)(11-29)(0- 4)(61-80)(2- 7) 
4 l wk. 46 16.5 10.77 7.23 .75 4 18.5 3 68.8 5 
(43-49 )( 16 -17 )( 8.5 -12.6)( 6. 87-8.07)(0-1)(2-7)(15-24)(2- 5)( 65-72)(4- 7) 
2 2 wk . 44. 5 17.3 14.13 7.08 0 5.5 21.5 4 66 3 
(44-45)(16.7-18.0)(12.36-15.9)(6.76-7.4)(0) (2-9)(13-30)(3- 5)(63-69)(2- 4) 
2 4 wk. 46 16.2 9.8 7.19 .5 2 21 1.5 71.5 4 
(45-47)( 16. 2 )( 8.99-10.6)(7.l -7. 28)(0-1)(1-3)(16-26)(0- 3)(71-72)(2- 6) 
Table 39. (Continued) 
HT HB WBC RBC Baso Eos Lym Eh Stab Seg Mono 
1 6 wk. 47 18.8 13.72 7.39 
Infarct sham (cont 1 } 
0 5 14 3 74 4 
2 12 wk. 50 18.5 10.93 8.12 0 4 19.5 5.5 64 7 
(50) (18-19} ( 10. 24-11. 62) ( 7. 32-8. 92) ( 0) ( 2-6) ( 19-20) { 4-7) { 61-67} ( 7) 
Epicarditis 
6 Pre-
sur- 48.5 19.95 9.298 7.107 .5 2.5 17.0 5.5 70.5 4.0 
gery (45-55) (16.4-19.0)(6.12-12.94)(5.38-8.59) (0-2) (l'.-'l) (9~23) (1-10) (66 -74) (2-6) 
5 1 wk. 43.2 16.2 13.576 7.12 .8 3.6 14.2 3.8 73.8 3.8 
(37-51) (14.2-17.8) (8.86-18.4) (4. 84-9.24) (0-3) (2-4) (10-19) (0-7) (70-79) (2-5) 
2 2 wk. 45 17.5 15.56 7.12 1 5 10 6 76.5 2 
( 44 -46) { 17. 4-17. 6) { 12. 5 -18. 6) { 6. 5 2-7. 72) ( 1) { 4-6) ( 8-12} ( 6) ( 7 4-79} ( 1-3) 
4 4 wk. 47 17.5 14.75 7.568 0 3.25 11.25 4.5 76.5 4.5 
(43-50) (16.0-18.8) (7.6-25.4} (6. 78-8.5) (0) (0-12) (10-13) (3-7) (67-84) (8-0) 
4 7 wk. 46.25 16 .85 14.91 7.717 .8 3.5 14.75 4 72.25 4.5 
(38-50)(15.1-18.0)(10.0-24.3)(6.0-8.48) (0-2)(2-8)(13-16)(1-9)(69-75)(3-6) 
6 11 wk. 47.67 16.86 12.02 7.672 1.5 7 17 2.33 66.8 5.33 
(43-55) (14.0-18.8) (7. 55-19.35) (6.65-8.55) (0-4) (3-13) (13-21) (0-7) (59-72) (2-8) 
Table 39. (Continued) 
No.Date HT Hb WBC RBC Baso Eos Lymph Stab Seg Mono 
Epicarditis (cont,) 
3 15 wk. 47.67 17.8 15.26 7.672 .33 6.67 19 4.6 67 4.3 
(56-51)(17.5-18.5)(10.4-22.5)(7.33-8.26)( 0-1)(1-12)(1-8)(1-8) (63-72) (2-7) 
5 19 wk. 46.2 17.3 10.8 7.31 .6 7.4 18.8 3.4 65.4 4.4 
(43-51)(15.0-18.8)(5.56-15.88)(5.73-8.32)(0-2)(3-11)(13-23)(0-7)(57-72)(2-10) 
3 23 wk. 49 17.6 12.29 7.83 .6 4.67 20 1.67 68.3 4.f!l 
(45-56)(12.5-18.8)(10.96-13,22)(7.15-9.39)(0-2)(4-6)(14-25)(0-3)(64-74)(4-5) 
1 27 wk. 40 
1 29 wk. 43 
18.8 
17.0 
11.22 
14.78 
5.83 
7.29 0 3 18 4 68 7 
Epicarditis sham 
3 Pre-
sur- 44 16.6 14.293 6.92 .33 2 18.67 3 71.3 4.67 
gery (40-46)(15.2-18.4)(13.44-14.82)(6.23-7.27)(0-l)(O-J)(9-25)(0-7)(56-91)(0-11) 
3 1 wk. 42.67 16.67 14.95 6.76 .33 1.67 18.3 6 69.3 4.33 
(41-44)(15.2-17.8)(13.7-16.64)(6.4-7.1) (0-1)(1-2)(13-21)(4-9)(63-77)(0-8) 
3 4 wk. 42 16 14.62 6.79 0 1.67 18 2.87 73.67 4.67 
(39-43)(15.1-16.8)(13.3-16.3)(6.46~7.43) (0) (1-3)(12-22)(2-3) (71-78)(4-6) 
Table 39. (Continued) 
No.Date HT Hb WBC RBC Baso Eos Lymph Stab Seg Mono 
Epicarditis sham (Cont.) 
2 7 wk. 49.5 17.5 15.32 8.28 (0) 8 15.5 9.5 62 5 
(47-52) (17- 18) (13.9-16. 74) (8.18-8.38) ( (0) (2-14) (10-21) (3-16) (54-70) (4-6) 
2 12 wk. 45.5 15.2 8.81 7.11 .5 2.5 28 2 
(45-46) (15-15.23) (6.65-10.96) (5.94-8.28) (0-1) (2-3) (22-34) (0-4) 
2 16 wk. 44.5 16.3 11.37 6.86 
(44-45)(15.6-17)(10.2-12.54)(7.39-6.32) 
1 20 wk. 46 17.4 5.40 6.20 
1 24 wk. 45 18.0 
1 27 wk. 46 18.4 
1 JO wk. 38 18.6 
1 36 wk. 45 16.0 
9.74 
12.96 
10.60 
8.24 
6.72 
8.28 
6.33 
7.50 
0 10 19.5 1 
(0)(5-15)(11-28)(0-2) 
0 2 21 6 
0 6 24 4 
0 2 25 3 
0 3 20 2 
0 6 21 4 
Valvular Insufficiency 
5 Pre-
56.5 10.5 
(44-69) (l-20) 
64 5.5 
( 51-77) ( 5 -6) 
62 10 
59 7 
67 3 
63 12 
63 6 
sur- 44.6 16.1 12.86 .7.28 .6 6.8 lJ.8 1,8 57.6 4.6 
gery(36-50)(14-17.2) (10.2-15.75)(6.18-8.71)( 0-1)(1-13)(2-19)(0-4)( 8-77) ( 0-9) 
5 1 w~34~ts~(13.3~~a:2)(9.51~i~~4)(5.23~7?g4)(0-2~,1~1~>,14~2~~,~-4)(64~?1Y,3~11> 
... '-=...,..,,_.-= --~ 
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Table 39. (Continued) 
No .Date HT Hb WBC RBC Baso Eso Lymph Stab Seg Mono 
VI (cont.) 
4 3 wk. 46.0 16.4 12.08 7.11 .75 6 18 2 66.5 6.75 
( 4 5 -4 7) ( 15 -17. 5 )( 6. 3 5 -18. 62 ) ( 6. 04 -8. 14) ( 0-2 ) ( 1-15 ) ( 14-22) ( 1-J ) ( 59 -78} ( 3 -10) 
5 7 wk. 44.6 16.08 12.17 7.18 .2 6.6 15.2 5.6 67.2 5.2 
(30-52) (lJ-19) (7.25-16. 74} ( 4.8-8.4} (0-1} (1-14} (13-19} (0-16) (54-78)(3-9) 
4 12 wk. 50 16.13 13.5 8.38 
(48-54)(15. 2-16,8)(11.3-19.96)(8,15-8.77} 
.5 6.5 18 2.5 68.5 4 
( 0-1 } ( 2 -11 ) ( 16 -19 ) ( 1 -5 ) ( 64 -7 3 } ( 3 -5 ) 
3 16 wk. 52 16.67 8.29 8.34 
(48-58)( 16-17 )(7.98-8.65)(6.12-8.65} 
0 3.33 22 2.67 64.67 7.33 
(0) (2-4) (14-34) (1-4) (56-70) (2-11) 
3 20 wk. 49.3 16,6 9.93 7.89 2 8.3 22 4.3 60.3 4 
(43-54)(15.8-17.2)(8.9-10.58)(6.56-8.58)(0-5)(5-14)(13-29)( 1-8)(50-74)(3-5) 
2 24 wk. 50 17.4 (13.11) 8.09 .5 1.5 17 4 70.5 6 
(49-51)(16.8-18) (9.65-16.56)(7.95-8.22)(0-1)(1-2)(15-19)( 2-6 )(69-72)(4-8) 
2 28 wk. 52 17.1 11.44 7.11 1.5 10 14.5 3 64.5 6.5 
(51-53)(16.2-18) (7.76-15.12)(66.8-7.53)(1-2)(6-14)(10-19)(2-4} (63-66)(6-7) 
2 32 wk. 505 17.2 8.51 7.76 
(48-53)(16.8-17.5)(8.18-8.9) 7.13-8.35)( 
1 11 21 4.5 60.5 2 
(l} (9-11) (14-29) (4-5) (51-70) (2} 
1 37 wk. 50 17.3 7.91 7.91 0 15 16 1 64 4 
1 42 wk. 50 16.9 10.5 8.46 6 3 23 3 65 6 
1 45 wk. 46 16.0 10.52 5.64 4 9 11 5 68 3 
Table 39. (Continued) 
No.Date HT Hb WBC RBC Basa Eos Lymph Stab Seg Mono 
Val~ular Insufficiency Sham 
5 Pre-
sur- 45.8 15.96 11,23 7.04 .8 3.4 26,2 3 62.2 4.4 
gery (38-52){12.3-19.4){7.04-14.75)(6.0-8.34)(0-4)(1-9)(21-34)(0-6)(51-70)(1-10) 
4 1 wk. 46.0 16.5 10.99 7.21 .5 4 24.5 3.5 63 4.5 
(44-49)(1.49-18,6){8.7-12.9)(6,8-7.96) (0-2)(2-8)(21-27)(0-5){57-68)(2- 8) 
2 4 wk, 42 13.3 13.0 6.67 5.5 5 12 6.5 60,5 10 
(38-46)(12.6-14) (10.35-15.65)(5.57-7.77H3-a(4-~(12) (3-10)(56-65)(5-15) 
2 8 wk. 42 15.05 14.3 6.43 1 10.5 29.5 6 48.5 4.5 
( 42) (15-15.1)(13.8-14.8) (5.9-6.95) (0-2)(10-11)(26-33)(5-7)(45-52)(2-7) 
2 13 wk. 46 16 16.6 7.77 0 9.5 25.5 8 50~ 6.5 
(45-47)(15.3-16.8)(16.14-17.06)(7.69-7.86)(0)(3-16)(15-46)(2-14){49-52)(3-10) 
1 16 wk. 50 17.0 14.04 7.47 1 6 26 8 53 6 
1 25 wk. 49 18.8 11.2 7.44 1 4 20 7 62 6 
Figure 10. Positioning of dog and placement of electrodes 
for serial ECG studies. 
Figure 11. Placement of electrodes for serial ECG study. 
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Figure 12. Heart from a dog sham-operated for myocardial 
infarction. 
Figure 13. Closeup of a heart from a dog sham-operated for 
myocardial infarction. 
Figure 14. Heart from dog 45 showing area of infarction at 
apex and a second smaller linear infarct between 
the papillary muscles. 
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Figure 15. 
Figure 16. 
Figure 17. 
Heart from dog 46 showing small infarct on tip 
of papillary muscle. 
Heart from dog 49 showing large area of fibrosis 
involving nearly one-half of the left ventricle 
musculature. 
Heart from dog 31 showing classical staircase 
infarction in posterior laterial wall of the 
left ventricle. 
+rl1 
Figure 18. 
Figure 19. 
Figure 20. 
Heart from dog 50 showing fibrosis and the 
severe decrease in thickness of the left 
ventricle musculature. 
Heart from dog34showing large infarction 
involving nearly all of the papillary muscle. 
Heart from dog 7 showing infarction near apex 
of left ventricle and the decrease in the 
thickness of the muscle mass. 
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Figure 21. Heart and pericardium from dog 37. (The 
pericardium could not be removed from the 
heart.) 
Figure 22. Heart and pericardium from dog 26 showing 
adhesions and epicarditis. 
Figure 23. An epicarditis-pericarditis heart from 
dog 36. 

Figure 24. 
Figure 25. 
Fi gure 26. 
Heart from dog 42 (notice dilatation of right 
ventricle and "pumpkin-shape" of the heart). 
Example of valvular insufficiency (Dog 27). 
Example of valvula r insufficiency (Dog 20). 
• 
Figure 27. Section of fibrosis of an infarcted area. 
(Shows junction with normal cardiac muscle 
tissue fixed in buffered, neutral formalin 
and stained with the Mallory triple stain. 
36X). 
Figure 28. Section of fibrotic area of an infarction. 
{Shows junction with normal cardiac muscle. 
Fixed in buffered, neutral formalin and 
stained with hematoxylin and eosin. 36X.) 
Figure 29. Increased magnification of Figure 28 (160X). 
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Figure 30. 
Figure 31. 
Figure 32. 
Section of fibrosis of an infarcted area. 
(Tissue fixed in buffered, neutral fonnalin 
and stained with the Mallory triple stain. 
240X.) 
Section of heart at junction of area of 
epicarditis with normal myocardium in dog 5. 
(Tissue fixed in buffered, neutral formalin 
and stained with the Mallory triple stain. 
36X.) 
Increased magnification of Figure 31. 
(Notice presence of giant cells (240X).) 
• 
lin 
.1. 
5. 
i n 
• 
184 
Figure 33. 
Figure 34. 
Figure 35. 
Section of heart at junction of area of 
epicarditis with normal myocardium in dog 
37. (Notice involvement of the myocardium. 
Fixed in buffered, neutral formalin and 
stained with hematoxylin and eosin 36X. ) 
Increased magnification of Figure 33 (240X). 
Section of a cusp from the right A-V valve 
showing increased thickness. (Tissue fixed 
in buffered, neutral formalin and stained 
with hematoxylin and eosin 36X.) 
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Figure 36. 
Figure 37. 
Figure 38. 
Liver from dog 42 showing early cardiac 
cirrhosis. 
Section of liver from dog 42. (Notice 
greatly enlarged central veins. Fixed 
in buffered, neutral formalin and stained 
with hematoxylin and eosin. 36X.) 
Increased magnification of Figure 37. 
(Notice cells around central vein in 
various stages of degeneration. 240X.) 
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Figure 39. 
Figure 40. 
,-,· 
ECG recording of a nonnal lead I with no Q-
wave and an upright T-wave. 
ECG recording of a normal lead I with no Q-
wave and an isoelectric T-wave. 
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Figure 41. 
Figure 42. 
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ECG recording of a normal lead I with a Q-
wave followed by an inverted T-wave. 
ECG recording of an abnormal lead I with a 
Q-wave followed by an upright T-wave. 
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Figure 43. 
Figure 44. 
ECG lead II recording from a dog taken 9 days 
f ollowin~ myocardial infarction showing a 
small S/T ratio and elevated ST segment. 
ECG lead III recording from a dog following 
infarction showing an inverted P-wave. 
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Figure 45. ECG recording of a normal lead III with S-
wave followed by an upright T-wave. 
Figure 46. ECG of an abnormal lead III with an S-wave 
followed by an inverted T-wave. 
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Figure 47. Abnormal ECG recording showing a Q-S 
complex in lead I. 
Figure 4g. Abnormal ECG recording showing a Q-S 
complex in lead III. 
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X. APPENDIX C: DATA 
A. Pathological Findings of Dogs with Cardiac Pathology 
1. Myocardial infarction 
There was an area of infarction at the right 
border of the left ventricle very near the apex. From the 
outside it showed as a small depressed area. Upon opening 
the heart there was an area of scar tissue about 2 cm. square 
and the thickness of the ventricular mass was about l cm. 
There were very few adhesions of lungs to thoracic wall and 
pericardia! sac. Other organs and tissues appeared to be 
normal. 
A very small infarct was found on the endo· 
cardial surface just ventral to the left anterior papillary 
muscle. This area was about 5 mm. in diameter. A second 
slightly larger infarction was seen more posteriorly on the 
endocardial surface of the left ventricle. There were no 
adhesions and other organs appeared to be normal. 
A small, shallow area of infarction slightly 
less than 1 cm. in diameter was found in the left ventricle 
about midway between the apex and base of the heart. There 
was a small area of adhesions of lung to the pericardium. 
The kidneys were yellow and appeared to be friable from 
fatty infiltration. Other organs and tissues appeared normal. 
·~ ... 
200 
An area of infarction approximately 1 . 5 cm. 
in diameter was seen on the anterior portion of the left 
endocardial surface about midway down the ventricular mass. 
Other organs and tissues were normal. 
Dog ~ The heart of this dog showed a transmural 
i nfarction. It was slightly over 1 cm. in diameter on the 
epicardial surface; however, it spread in three fingers down 
to the apex on the endocardial surface . The involved area 
commenced over the interventricular septum about one-half 
of the way do\om the left ventricle. There were some adhesions 
of the pericardial sac to the epicardium. There were no 
adhesions of the lungs. The liver appeared to be swollen 
grossly and upon microscopic examination there was evidence 
of fat t y infiltration. Other tissues seemed to be normal. 
On the epicardial s~rface there was very 
little indication of pathology. Upon palpation a very thin 
area was found in the apex of the left ventricle. A hard 
mass was found near the region of the atria~ventricular 
junction in the posterior portion of the left ventricle. 
Upon opening the heart a large fibrotic area was seen in the 
apex of the left ventricle about 3 cm. in dia meter. There 
was a fibrotic streak 5 mm. wide and a bout 2. 25 cm. in 
length between the two papillary muscles extending fro m the 
A-V junction to the base of the a nterior papillar y muscle . 
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There were some adhesions of the pericardia! sac to the 
epicardium and to the lungs. The left diaphragmatic lobe 
showed areas of grey hepatization. There were no significant 
changes in the other tissues. 
Dog .l! There was no indication of pathology from 
the external appearance of the heart except for a small area 
of adhesions of the pericardial sac to the epicardium in the 
area of pericardial suturing. Upon opening the left ven-
tricle an abnormal area could be seen extending diagnally 
across the heart wall. It extended from below the papillary 
muscle almost to the attachment of the A-V valves on the 
posterior lateral wall. Its total length was nearly 7 cm. 
and it was 2 cm. wide at its greatest width very near the 
papillary muscle. Its width generally was between 1 and 1.5 
cm. There were twv fresh infarcts in the spleen. There 
was an old infarct on the left kidney. These were all small 
infarctions. The liver was hyperemic, but appeared normal 
otherwise. Other tissues were normal. 
Dog .Jl!:. There were a few adhesions of the pericardial 
sac to the lungs and epicardium. There was a fibrotic area 
on the surface of the left ventricle. Upon opening the 
heart an extensive fibrotic area was evident. It extended 
for a distance of 7 cm. from the base of the papillary 
muscle to the apex of the heart in the area of the ven-
tricular septum; however, the septum did not appear to be 
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involved. This area was approximately 3. 5 cm. at its widest 
point and was more or less wedge-shaped with its point at 
the apex of the heart. The area around it was hyperemic and 
there were several rays of necrotic tissue extending from 
the mass of fibrosis. Liver appeared to be swollen and there 
was some cloudy swelling upon microscopic examination . Other 
tissues seemed to be normal. 
Dog J1i This dog showed a fairly extensive area of 
epicarditis. The pericardial sac was adhered to approxi-
mately two-thirds of the epicardial surface . A small area of 
infarction was present on the endocardial surface in the base 
of the papillary muscle. This did not extend very deeply 
into the myocardium; however, there appeared to be 3 small 
projections of necrotic tissue extending towards the apex 
of the heart from the area of fibrosis . There seemed to be 
no significant changes in any of the other tissues. 
This dog was allowed to exercise several weeks 
after production of the infarct. 1He did real well. How-
ever, he became tired in a relatively short time and would 
refuse to play or run for several minutes . After this short 
rest he would again resume normal activity. There were no 
other indications of any stress. Upon necropsy all tissues 
and organs were normal with the exception of the heart. An 
area of infarction about 3 cm. long and 2 cm. wide was seen 
in the left ventricular wall. This was not transmural, but 
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the entire muscle-fibrotic mass was reduced to a width of 
about 1 cm. In addition a slight valvular endocarditis was 
present on the left A-V valve. 
Dog !r.Q. There were no adhesions of the pericardial 
sac to the lungs or of the lungs to the pleura. There was 
a very small area of adhesions of the sac to the epicardium 
which was easily broken down. Heart appeared normal from 
the epicardial surface. On opening the heart an area of 
fibrotic tissue about 1 cm. in diameter was found on the 
papillary muscle where the chordae tendinae attach. Other 
tissues were normal. 
Dog !t5l. This dog had the greatest amount of in-
farcted tissue. Upon palpation the left ventricle was 
nearly as thin as the atria and had much the same consis-
tency. The fibrotic area covered the entire extent of the 
endocardial surface from the apex to about one-third of the 
way up the papillary muscles. The interventricular septum 
was also involved somewhat near the apex. The epicardial 
surface appeared to be normal. 
The left lobe of the lung had some exudate in the 
bronchi and a few small areas of pneumonia were present. The 
left kidney was swollen and hyperemic; the other kidney was 
normal. Other organs seemed to be normal. 
Dog iQ This dog showed a transmural infarct of the 
anterior left apex. It was about 3 cm. in diameter 
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encroaching on the lower part of the anterior papillary 
muscle. There was also some involvement of the septum near 
the apex. The center area was very thin, approximately 5 
mm. in thickness. Other organs showed no significant 
changes. 
There were a few adhesions of lungs to the 
pleura and pericardial sac and of the sac to the epicardium. 
There was no evidence of pathology from external appearance 
of the heart. Upon opening the heart, the involved area was 
not nearly so well defined as seen previously in other dogs. 
There was necrosis, but not nearly as much fibrosis had oc-
curred. The infarct covered an area from the middle of the 
anterior papillary muscle to near the apex of the heart in a 
wedge-shape with its apex in the papillary muscle. This area 
was about 1.5 cm. tdde at its widest point and nearly 3 cm. 
long. It appeared to be only about 1 cm. deep. 
2. Epicarditis 
There were no adhesions of the lungs. The 
pericardial sac of this animal was nearly normal. There was 
a diffuse epicarditis with the right side being more in-
volved than the left. There was a slight valvular endo-
carditis of one cusp of the tricuspid valve. There was a 
slight right heart dilatation. The spleen was large and 
appeared nodular. Other organs looked normal . 
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This dog showed a severe pericarditis and 
much of the epicardium was involved. Some areas of pete-
chiation and a lot of hyperemia were present. Fluids were 
minimal. The liver was slightly swollen and congested. The 
spleen was large and congested. The kidneys were very dark, 
nearly black, in color but of normal size and consistency. 
Other organs appeared to be normal. 
Dog 26 The pericardium of this dog was severely 
involved. It was nearly 5 mm. thick. There was a mild 
epicarditis throughout with a minimum of hyperemia and almost 
no hemorrhage. There were two small cysts which appeared to 
be encased talcum powder. There were no adhesions of the 
lungs to the pericardium or the pleura. Other organs in-
dicated no pathology. 
Dog .lQ The pericardia! sac was adhered to the lungs 
and the pleural wall, and part of the cardiac lobe of the 
right lung was atelectatic. There was an extensive epi-
carditis on the right side which extended to the left. There 
was a large amount of petechial hemorrhage and hyperemia. 
Other tissues and organs were normal. 
Dog J.Z This dog died during the night about three 
months after pathology had been induced and had severe post-
mortem changes when necropsied. The thoracic cavity was 
full of fluids and there was little functional lung rema i ning . 
There were many large vessels extending into the pericardium. 
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The pericardial sac was entirely adhered to the epicardium 
and was impossible to remove. There was a small amount of 
dark, viscous fluid in the sac. It did have an odor. The 
heart muscle was hypertrophied and the chambers were smaller 
than normal. The auricles were almost entirely fibrotic. 
Other organs were badly decomposed and could not be studied 
effectively. 
There were some adhesions of the right lung 
to the pleura and pericardium. Mediastinum was thickened 
with many large vessels in it. The pericardial sac was 
completely adhered to the epicardium. Epicarditis involved 
the entire surface of the heart. There was little or no 
exudate. The right ventricle was considerably dilated and 
the tissue had a very soft, flabby consistency. Other organs 
showed no significant changes. 
3. Valvular insufficiency 
This dog showed a minimal amount o f right 
valvular insufficiency with one cusp having a cut about one-
half of the way through , yet the right atrium was very 
dil ated. The heart looked normal other than this. Other 
or gans and tissues appeared to be normal. 
Dog 22. The right ventricle was hypertrophied and 
the atrium was dilated. One cusp of the right A-V val ve was 
completely de stroyed. Liver was swollen slightly and some-
what conges t ed , but there was no i ndicat ion of necrosis upon 
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microscopic examination. The spleen was large and knobby. 
Other organs and tissues showed no significant changes. 
Dog lQ The heart showed very little evidence of 
pathology from external appearance. The medial cusp of the 
right A-V valve was cut and the edges were granulated. Two 
tendinae were also cut, but the valve probably remained 
partially functional. There was a small lesion on the 
right kidney which may have been a cyst. Other tissues and 
organs looked normal. 
Dog ~ This dog had a very dilated heart. The left 
A-V valve had one cusp which was adhered to the endocardium. 
The right A-V valve had a mild vegetative endocarditis on 
all cusps. The liver was swollen and very hyperemi~. There 
was evidence of necrosis around the central veins upon 
microscopic examination. Other organs were hyperemic but 
showed no other pathology. 
Dog ~ This dog had the most severe valvular insuf-
ficiency of the five dogs in this group. One cusp of the 
right A-V valve was completely destroyed and a small cut was 
present in the second cusp. There was also a piece of granu-
lation tissue extending from the area of the cut into the 
atrium. 
The pleural and peritonal cavities were partially fil l ed 
with fluids . The left lung was collapsed and very little of 
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the right was still functional. Other organs and tissues were 
very edematous. 
The liver was partially cirrhotic and swollen. A severe 
passive hyperemia was present throughout the body. Upon 
histolo'gical examination there was necrosis around the 
central veins; other liver cells were in various stages of 
degeneration. 
Hergt and Langin Method (64) for SGOT Determination 
(All materials listed below, except the buffer, are 
co~~ercially obtainable from the California Foundation of 
Biochemical Research, 3408 Fowler Street, Los Angeles 63, 
California. ) 
Phosphate Buffer, 0.1 M., pH 7.5: 84 parts O.l M. 
dibasic sodium phosphate (Na2 HP04 ) are combined with 16 
parts 0.1 M. monobasic potassium phosphate (KH2 P04 ). The 
solutions are stored separately in the refrigerator and dis-
carded if growth of mold appears. 
Reduced diphosphopridine nucleotide (DPNH): DPNH in 
solution is very unstable, but it can be stored dry in-
definitely with no loss of activity. 
Five mg. of powdered DPNH are weighed on a sheet of 
parafilm and divided into 12 parts of about equal size with 
a scalpel blade and each portion is placed into a small 
(12 x 75 mm.) test tube. The tubes are placed in a desicator 
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over night in the dark, then sealed with paraffinized corks, 
and stored in the refrigerator. Each tube contains enough 
DPNH for two determinations. The contents are dissolved in 
1.4 ml. of buffer for use. 
Aspartic Acid, 0.05 M: 333.0 mg. aspartic acid are 
dissolved in 50.0 ml. of buffer, and the pH adjusted to 
approximately 7.5 with 1 or 2 drops of saturated sodium hy-
droxide (NaOH). The solution is then stored in the refrig -
erator and prepared anew if growth of mold appears. 
Alpha ketoglutaric acid, 0.1 M: Because of the in-
stability of this material in solution, a similar technique 
as in the preparation of DPNH is employed. 
Seventy-six mg . of alpha -ketoglutaric acid are weighed 
on a sheet of parafilm and divided into 12 equal portions. 
The material is then distributed into 12 small test tubes, 
placed in a desicator over night, then stoppered with para-
finized corks , and stored at room temperature. For use, the 
contents of a tube are dissolved in 0.5 ml. of buffer. Each 
tube contains enough material for two determinations. 
Malic Dehydrogenase, stabilized: This is used as it is 
supplied ; the enzyme concentration varies with each lot. It 
is indicated on the label and must be checked carefully 
before use. A total of 200 units is required for each deter-
mination and the quantity is transferred directly from the 
vial into the cells by means of a micropipette at the time 
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of actual determination. The material is stored in the 
r efrigerator. 
Procedure: 
1. Set up the Beckman Model B spectrophotometer in the 
usual manner using a blue-sensitive phototube with 
a 500 megohm resistor and a blue filter. The wave 
length setting is 340 mµ. 10 mm. cells are used (pyrex 
.quality). 
2. Use nonhemolyzed serum fresh or after freezing or 
refrigeration. 
3. Remove all test constituents from the refrigerator 
and allow to come to room temperature . Mix the 
phosphate solution proportionately as indicated above. 
4. Add 0. 5 ml. and 1.4 ml . of the buffer to t he tube i 
containing alpha - ketoglutaric acid and DPNH, 
r espectively. 
5. Using two cells , pipette as follows : 
Buff er 
DPNH 
Aspartic Acid 
Malic Dehydrogenas e 
Ser um 
Blank Unknown 
2. 9 ml. 
0. 7 ml. 
2. 0 ml. 
200 units 
O.l ml.O.l ml. 
Mi x wel l , let st and for 10 minutes at r oom temper a -
ture . 
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6. Add 0.2 ml. of alpha - ketoglutaric acid to the 
unknown. Mix well. 
7. Set the instrument to 0 O.D. with the blank and 
then read O.D. of the unknown immediately. Repeat 
readings after timed intervals, usually 5 minutes. 
Two equally timed intervals are sufficient if the re-
sults agree within 10 percent of each other. 
Calculations: 
The change (decrease) in O.D. during timed intervals i s 
averaged and divided by the average time per interval 
to obtain the average change in O.D. in one minute. 
Since one unit of GOT actiYity is defined as a decrease 
in O.D. of 0.001 per minute, using 1.0 ml. serum, the 
above quotient is multiplied by JJ,000 to obtain 
"units of transaminase activity per ml." of the unknown 
material. 
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Example of Statistical Analysis 
(Hergt vs. Sigma Methods for 
: Unit SGOT : X= 
Sample No . :Hergt:Sigma :Diff, 
1 113 133 20 
2 82 140 58 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
_Total 
85 170 85 
100 75 -25 
188 193 5 
106 '140 36 
87 105 18 
70 80 10 
128 139 11 
280 320 40 
241 260 19 
122 102 -20 
320 410 
295 370 
90 
75 
110 150 40 
185 305 120 
260 400 140 
155 235 80 
160 240 80 
95 82 -13 
3182 4049 909 
Measuring SGOT Concentrations} 
S
2 = i,( X-x) 2 ~ 2 
N-1 = <.X 
[X2 = 78135 (~X} 2 = 826281 
(~X ) 2 826281 
f:X 2 - N = 78135 - 20 
= 78 ,135 - 41,314.05 
36, 820. 95 
19 s2 = 
S2 = 1,937 . 94 
s2 s~ = 20 = 96. 90 x 
45.45 
t = 9 . 83 = 4.62• 
•student t-test significant 
at the 0,1 percent level tha t 
there is a difference in the 
two tests. 
x = 45.45 
